##ANALYSISTYPE=CLINCNV_GERMLINE_SINGLE
##gender of sample: M
##number of iterations: 1 , quality used at final iteration: 20
##was it outlier after clustering? FALSE
##fraction of outliers: 0.049
#chr	start	end	CN_change	loglikelihood	no_of_regions	length_KB	potential_AF	genes	qvalue	cn_polymorphisms_zarrei	cn_polymorphisms_demidov	dosage_sensitive_disease_genes	omim
chr1	983382	983755	1	6	1	   0.373	0.057	AGRN	0.01920	yes			103320_[AGRN_Myasthenic_syndrome,congenital,8,with_pre-_and_postsynaptic_defects,615120]
chr1	1960540	1961211	1	7	2	   0.671	0.025	GABRD	0.03429			GABRD	137163_[GABRD_Epilepsy,generalized,with_febrile_seizures_plus,type_5,susceptibility_to,613060/Epilepsy,idiopathic_generalized,10,613060/Epilepsy,juvenile_myoclonic,susceptibility_to,613060]
chr1	2337913	2338068	3	4	1	   0.155	0.140	PEX10	0.04650				602859_[PEX10_Peroxisome_biogenesis_disorder_6A_(Zellweger),614870/Peroxisome_biogenesis_disorder_6B,614871]
chr1	5987699	5987857	3	8	1	   0.158	0.089	NPHP4	0.01940				607215_[NPHP4_Nephronophthisis_4,606966/Senior-Loken_syndrome_4,606996]
chr1	6545886	6546024	1	3	1	   0.138	0.083	PLEKHG5	0.03925				611101_[PLEKHG5_Spinal_muscular_atrophy,distal,autosomal_recessive,4,611067/Charcot-Marie-Tooth_disease,recessive_intermediate_C,615376]
chr1	12066585	12066760	1	6	1	   0.175	0.038	MFN2	0.01209				608507_[MFN2_Charcot-Marie-Tooth_disease,axonal,type_2A2A,609260/Hereditary_motor_and_sensory_neuropathy_VIA,601152/Charcot-Marie-Tooth_disease,axonal,type_2A2B,617087]
chr1	17312948	17314739	1	3	4	   1.791	0.064	ATP13A2	0.05003				610513_[ATP13A2_Kufor-Rakeb_syndrome,606693/Spastic_paraplegia_78,autosomal_recessive,617225]
chr1	17326731	17327039	1	3	2	   0.308	0.210	ATP13A2	0.14065				610513_[ATP13A2_Kufor-Rakeb_syndrome,606693/Spastic_paraplegia_78,autosomal_recessive,617225]
chr1	19205784	19205877	1	6	1	   0.093	0.057	ALDH4A1	0.01277				606811_[ALDH4A1_Hyperprolinemia,type_II,239510]
chr1	22157946	22158065	1	6	1	   0.119	0.057	HSPG2	0.01367			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22176524	22178736	1	4	5	   2.212	0.076	HSPG2	0.07866			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22214421	22214569	1	4	1	   0.148	0.038	HSPG2	0.01713			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22979672	22979806	3	3	1	   0.134	0.261	C1QB	0.06690				120570_[C1QB_C1q_deficiency,613652]
chr1	24122631	24122765	1	4	1	   0.134	0.057	GALE	0.03623				606953_[GALE_Galactose_epimerase_deficiency,230350]
chr1	24124175	24124371	3	5	1	   0.196	0.210	GALE	0.04793				606953_[GALE_Galactose_epimerase_deficiency,230350]
chr1	24151836	24151959	4	10	1	   0.123	0.197	HMGCL	0.00238				613898_[HMGCL_HMG-CoA_lyase_deficiency,246450]
chr1	24172554	24172673	3	6	1	   0.119	0.153	FUCA1	0.02518				612280_[FUCA1_Fucosidosis,230000]
chr1	33282779	33283643	3	4	1	   0.864	0.166	S100PBP,YARS	0.03097				603623_[YARS_Charcot-Marie-Tooth_disease,dominant_intermediate_C,608323]
chr1	33480113	33487072	3	4	2	   6.959	0.134	AK2	0.18139				103020_[AK2_Reticular_dysgenesis,267500]
chr1	33502327	33502522	3	5	1	   0.195	0.134	AK2	0.03348				103020_[AK2_Reticular_dysgenesis,267500]
chr1	40562777	40724076	3	7	2	 161.299	0.096	PPT1,ZMPSTE24	0.00964	yes			600722_[PPT1_Ceroid_lipofuscinosis,neuronal,1,256730],606480_[ZMPSTE24_Mandibuloacral_dysplasia_with_type_B_lipodystrophy,608612/Restrictive_dermopathy,lethal,275210]
chr1	43203890	43203994	1	3	1	   0.104	0.089	CLDN19	0.07361				610036_[CLDN19_Hypomagnesemia_5,renal,with_ocular_involvement,248190]
chr1	43205502	43205935	1	5	1	   0.433	0.070	CLDN19	0.01336				610036_[CLDN19_Hypomagnesemia_5,renal,with_ocular_involvement,248190]
chr1	43224513	43225071	3	4	2	   0.558	0.083	P3H1	0.02994				610339_[P3H1_Osteogenesis_imperfecta,type_VIII,610915]
chr1	43396707	43396887	3	14	1	   0.180	0.070	SLC2A1	0.00123			SLC2A1	138140_[SLC2A1_GLUT1_deficiency_syndrome_1,infantile_onset,severe,606777/GLUT1_deficiency_syndrome_2,childhood_onset,612126/Epilepsy,idiopathic_generalized,susceptibility_to,12,614847/Dystonia_9,601042/Stomatin-deficient_cryohydrocytosis_with_neurologic_defects,608885]
chr1	45392290	45392421	3	4	1	   0.131	0.242	EIF2B3	0.07668				606273_[EIF2B3_Leukoencephalopathy_with_vanishing_white_matter,603896]
chr1	46663364	46663553	3	3	1	   0.189	0.236	POMGNT1	0.08833			POMGNT1	606822_[POMGNT1_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,3,253280/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,3,613151/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,3,613157/Retinitis_pigmentosa_76,617123]
chr1	53662091	53662777	3	5	1	   0.686	0.178	CPT2	0.02796				600650_[CPT2_CPT_II_deficiency,myopathic,stress-induced,255110/CPT_II_deficiency,infantile,600649/CPT_II_deficiency,lethal_neonatal,608836/Encephalopathy,acute,infection-induced,4,susceptibility_to,614212]
chr1	92949282	92949366	4	5	1	   0.084	0.357	GFI1	0.02479				600871_[GFI1_Neutropenia,severe_congenital_2,autosomal_dominant,613107/Neutropenia,nonimmune_chronic_idiopathic,of_adults,607847]
chr1	98386430	98386625	3	4	1	   0.195	0.166	DPYD	0.03106			DPYD	612779_[DPYD_Dihydropyrimidine_dehydrogenase_deficiency,274270/5-fluorouracil_toxicity,274270]
chr1	100315630	100315981	3	6	1	   0.351	0.146	AGL	0.01932				610860_[AGL_Glycogen_storage_disease_IIIa,232400/Glycogen_storage_disease_IIIb,232400]
chr1	100381956	100382063	3	5	1	   0.107	0.076	AGL	0.02613				610860_[AGL_Glycogen_storage_disease_IIIa,232400/Glycogen_storage_disease_IIIb,232400]
chr1	100671776	100671867	3	3	1	   0.091	0.121	DBT	0.07509				248610_[DBT_Maple_syrup_urine_disease,type_II,248600]
chr1	100715316	109756760	3	6	2	9041.444	0.159	DBT,SARS	0.01022	yes	yes	COL11A1,AMY1A	248610_[DBT_Maple_syrup_urine_disease,type_II,248600],603504_[CDC14A_Deafness,autosomal_recessive_32,with_or_without_immotile_sperm,608653],607468_[GPR88_Chorea,childhood-onset,with_psychomotor_retardation,616939],120280_[COL11A1_Stickler_syndrome,type_II,604841/Marshall_syndrome,154780/Lumbar_disc_herniation,susceptibility_to,603932/Fibrochondrogenesis_1,228520],618016_[RNPC3_Growth_hormone_deficiency,isolated,type_V,618160],608744_[SLC25A24_Fontaine_progeroid_syndrome,612289],609245_[GPSM2_Chudley-McCullough_syndrome,604213],600774_[TAF13_Mental_retardation,autosomal_recessive_60,617432],607529_[SARS_Neurodevelopmental_disorder_with_microcephaly,ataxia,and_seizures,617709]
chr1	115259269	115259525	4	6	1	   0.256	0.236	NRAS	0.02518				164790_[NRAS_RAS-associated_autoimmune_lymphoproliferative_syndrome_type_IV,somatic,614470/Noonan_syndrome_6,613224/Epidermal_nevus,somatic,162900/Thyroid_carcinoma,follicular,somatic,188470/Colorectal_cancer,somatic,114500/Melanocytic_nevus_syndrome,congenital,somatic,137550/Neurocutaneous_melanosis,somatic,249400/Schimmelpenning-Feuerstein-Mims_syndrome,somatic_mosaic,163200]
chr1	149804211	149832735	3	17	2	  28.524	0.153	HIST2H4A,HIST2H4B	0.00331	yes			
chr1	154143115	154143197	3	7	1	   0.082	0.089	TPM3	0.01385				191030_[TPM3_Nemaline_myopathy_1,autosomal_dominant_or_recessive,609284/CAP_myopathy_1,609284/Myopathy,congenital,with_fiber-type_disproportion,255310]
chr1	154245029	154246447	3	4	3	   1.418	0.153	HAX1	0.06625				605998_[HAX1_Neutropenia,severe_congenital_3,autosomal_recessive,610738]
chr1	155262958	155263144	3	4	1	   0.186	0.070	PKLR	0.04262				609712_[PKLR_Pyruvate_kinase_deficiency,266200/Adenosine_triphosphate,elevated,of_erythrocytes,102900]
chr1	156024507	156024758	5	9	1	   0.251	0.293	LAMTOR2	0.02518				610389_[LAMTOR2_Immunodeficiency_due_to_defect_in_MAPBP-interacting_protein,610798]
chr1	160251819	160252000	3	6	1	   0.181	0.032	DCAF8,PEX19	0.02064				615820_[DCAF8_Giant_axonal_neuropathy_2,autosomal_dominant,610100],600279_[PEX19_Peroxisome_biogenesis_disorder_12A_(Zellweger),614886]
chr1	160254835	161136472	3	17	2	 881.637	0.229	DCAF8,PEX19,PPOX	0.01463	yes			615820_[DCAF8_Giant_axonal_neuropathy_2,autosomal_dominant,610100],600279_[PEX19_Peroxisome_biogenesis_disorder_12A_(Zellweger),614886],601924_[COPA_Autoimmune_interstitial_lung,joint,and_kidney_disease,616414],605254_[NCSTN_Acne_inversa,familial,1,142690],600533_[VANGL2_Neural_tube_defects,182940],605554_[CD244_Rheumatoid_arthritis,susceptibility_to,180300],191523_[USF1_Hyperlipidemia,familial_combined,susceptibility_to,602491],609607_[NECTIN4_Ectodermal_dysplasia-syndactyly_syndrome_1,613573],610554_[UFC1_Neurodevelopmental_disorder_with_spasticity_and_poor_growth,618076],600923_[PPOX_Porphyria_variegata,176200]
chr1	161277038	161277224	3	4	1	   0.186	0.159	MPZ	0.04579			MPZ	159440_[MPZ_Charcot-Marie-Tooth_disease,type_1B,118200/Dejerine-Sottas_disease,145900/Hypomyelinating_neuropathy,congenital,2,618184/Charcot-Marie-Tooth_disease,type_2J,607736/Roussy-Levy_syndrome,180800/Charcot-Marie-Tooth_disease,type_2I,607677/Charcot-Marie-Tooth_disease,dominant_intermediate_D,607791]
chr1	167487635	173794504	3	6	2	6306.869	0.108	CD247,DARS2	0.01685	yes	yes		186780_[CD247_Immunodeficiency_25,610163],605205_[ADCY10_Hypercalciuria,absorptive,susceptibility_to,143870],604614_[TBX19_Adrenocorticotropic_hormone_deficiency,201400],182330_[ATP1B1_Blood_pressure_regulation_QTL,145500],603941_[SLC19A2_Thiamine-responsive_megaloblastic_anemia_syndrome,249270],612309_[F5_Factor_V_deficiency,227400/Thrombophilia,susceptibility_to,due_to_factor_V_Leiden,188055/Stroke,ischemic,susceptibility_to,601367/Budd-Chiari_syndrome,600880/Thrombophilia_due_to_activated_protein_C_resistance,188055/Pregnancy_loss,recurrent,susceptibility_to,1,614389],607983_[GORAB_Geroderma_osteodysplasticum,231070],167420_[PRRX1_Agnathia-otocephaly_complex,202650],136132_[FMO3_Trimethylaminuria,602079],601652_[MYOC_Glaucoma_1A,primary_open_angle,137750],617987_[EEF1AKNMT_Deafness,autosomal_recessive_26,modifier_of,605429],601730_[PIGC_Glycosylphosphatidylinositol_biosynthesis_defect_16,617816],134638_[FASLG_Autoimmune_lymphoproliferative_syndrome,type_IB,601859/Lung_cancer,susceptibility_to,211980],603594_[TNFSF4_Myocardial_infarction,susceptibility_to,608446],610956_[DARS2_Leukoencephalopathy_with_brain_stem_and_spinal_cord_involvement_and_lactate_elevation,611105]
chr1	183187515	183187633	3	5	1	   0.118	0.083	LAMC2	0.02862				150292_[LAMC2_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,junctional,non-Herlitz_type,226650]
chr1	183556020	183559749	3	3	2	   3.729	0.166	NCF2	0.12274				608515_[NCF2_Chronic_granulomatous_disease_due_to_deficiency_of_NCF-2,233710]
chr1	197113077	197115834	3	4	2	   2.757	0.217	ASPM	0.14065				605481_[ASPM_Microcephaly_5,primary,autosomal_recessive,608716]
chr1	198691535	198691615	1	3	1	   0.080	0.580	PTPRC	0.59336				151460_[PTPRC_Hepatitis_C_virus,susceptibility_to,609532/Severe_combined_immunodeficiency,T_cell-negative,B-cell/natural_killer-cell_positive,608971]
chr1	201022327	201022412	1	3	1	   0.085	0.089	CACNA1S	0.04961				114208_[CACNA1S_Hypokalemic_periodic_paralysis,type_1,170400/Malignant_hyperthermia_susceptibility_5,601887/Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580]
chr1	201054554	201054719	0	14	1	   0.165	0.433	CACNA1S	0.01144				114208_[CACNA1S_Hypokalemic_periodic_paralysis,type_1,170400/Malignant_hyperthermia_susceptibility_5,601887/Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580]
chr1	201061090	201061252	3	4	1	   0.162	0.121	CACNA1S	0.07527				114208_[CACNA1S_Hypokalemic_periodic_paralysis,type_1,170400/Malignant_hyperthermia_susceptibility_5,601887/Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580]
chr1	215813890	215814086	3	3	1	   0.196	0.197	USH2A	0.06675				608400_[USH2A_Usher_syndrome,type_2A,276901/Retinitis_pigmentosa_39,613809]
chr1	220330602	220330840	3	4	1	   0.238	0.025	RAB3GAP2	0.01707				609275_[RAB3GAP2_Martsolf_syndrome,212720/Warburg_micro_syndrome_2,614225]
chr1	220368630	220368729	3	4	1	   0.099	0.025	RAB3GAP2	0.03348				609275_[RAB3GAP2_Martsolf_syndrome,212720/Warburg_micro_syndrome_2,614225]
chr1	220445555	222988523	3	10	2	2542.968	0.166	RAB3GAP2	0.00856	yes	yes		609275_[RAB3GAP2_Martsolf_syndrome,212720/Warburg_micro_syndrome_2,614225]
chr1	225609769	225616567	3	9	3	   6.798	0.102	LBR	0.00888				600024_[LBR_Pelger-Huet_anomaly,169400/Greenberg_skeletal_dysplasia,215140/Reynolds_syndrome,613471/Pelger-Huet_anomaly_with_mild_skeletal_anomalies,618019]
chr1	231376909	231377212	4	25	1	   0.303	0.178	C1ORF131,GNPAT	0.00000				602744_[GNPAT_Rhizomelic_chondrodysplasia_punctata,type_2,222765]
chr1	235530718	235530877	4	12	1	   0.159	0.146	TBCE	0.00107			TBCE	604934_[TBCE_Kenny-Caffey_syndrome,type_1,244460/Hypoparathyroidism-retardation-dysmorphism_syndrome,241410/Encephalopathy,progressive,with_amyotrophy_and_optic_atrophy,617207]
chr1	235964161	235964407	3	4	1	   0.246	0.013	LYST	0.02753				606897_[LYST_Chediak-Higashi_syndrome,214500]
chr1	235967794	235967975	3	4	1	   0.181	0.178	LYST	0.05685				606897_[LYST_Chediak-Higashi_syndrome,214500]
chr1	236958571	236959047	3	7	1	   0.476	0.146	MTR	0.01665				156570_[MTR_Homocystinuria-megaloblastic_anemia,cblG_complementation_type,250940/Neural_tube_defects,folate-sensitive,susceptibility_to,601634]
chr2	1520645	1520764	3	5	1	   0.119	0.140	TPO	0.02540			TPO	606765_[TPO_Thyroid_dyshormonogenesis_2A,274500]
chr2	25391357	25391569	1	6	1	   0.212	0.102	POMC	0.01768				176830_[POMC_Obesity,adrenal_insufficiency,and_red_hair_due_to_POMC_deficiency,609734/Obesity,early-onset,susceptibility_to,601665],603202_[POMC_Lactase_deficiency,congenital,223000]
chr2	26507741	26507835	1	3	1	   0.094	0.032	HADHB	0.02518				143450_[HADHB_Trifunctional_protein_deficiency,609015]
chr2	26508265	26508449	3	4	1	   0.184	0.236	HADHB	0.04952				143450_[HADHB_Trifunctional_protein_deficiency,609015]
chr2	27535851	27545399	3	7	2	   9.548	0.115	MPV17	0.01920				137960_[MPV17_Mitochondrial_DNA_depletion_syndrome_6_(hepatocerebral_type),256810]
chr2	27590603	27591016	3	7	2	   0.413	0.038	EIF2B4	0.00780				606687_[EIF2B4_Leukoencephalopathy_with_vanishing_white_matter,603896/Ovarioleukodystrophy,603896]
chr2	27591863	27593334	4	4	3	   1.471	0.210	EIF2B4	0.10112				606687_[EIF2B4_Leukoencephalopathy_with_vanishing_white_matter,603896/Ovarioleukodystrophy,603896]
chr2	31805680	31806050	1	6	1	   0.370	0.140	SRD5A2	0.02829			SRD5A2	607306_[SRD5A2_Pseudovaginal_perineoscrotal_hypospadias,264600]
chr2	32361936	32362267	3	2	2	   0.331	0.045	SPAST	0.07551				604277_[SPAST_Spastic_paraplegia_4,autosomal_dominant,182601]
chr2	44139561	44139707	3	3	1	   0.146	0.191	LRPPRC	0.07178				607544_[LRPPRC_Leigh_syndrome,French-Canadian_type,220111]
chr2	45169027	45170059	1	4	1	   1.032	0.025	SIX3	0.03262			SIX3	603714_[SIX3_Holoprosencephaly_2,157170/Schizencephaly,269160]
chr2	58456939	61244996	3	8	3	2788.057	0.217	FANCL,PEX13,PUS10	0.02479	yes			608111_[FANCL_Fanconi_anemia,complementation_group_L,614083],606557_[BCL11A_Dias-Logan_syndrome,617101],142335_[BCL11A_Fetal_hemoglobin_QTL5],601789_[PEX13_Peroxisome_biogenesis_disorder_11A_(Zellweger),614883/Peroxisome_biogenesis_disorder_11B,614885]
chr2	69581611	69581710	3	4	1	   0.099	0.019	GFPT1	0.01920				138292_[GFPT1_Myasthenia,congenital,12,with_tubular_aggregates,610542]
chr2	71801318	71801511	1	5	1	   0.193	0.051	DYSF	0.00964				603009_[DYSF_Muscular_dystrophy,limb-girdle,autosomal_recessive_2,253601/Myopathy,distal,with_anterior_tibial_onset,606768/Miyoshi_muscular_dystrophy_1,254130]
chr2	74153943	74154189	3	5	1	   0.246	0.197	DGUOK	0.02450				601465_[DGUOK_Mitochondrial_DNA_depletion_syndrome_3_(hepatocerebral_type),251880/Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions,autosomal_recessive_4,617070/Portal_hypertension,noncirrhotic,617068]
chr2	74589767	74590564	3	5	3	   0.797	0.038	DCTN1	0.08600				601143_[DCTN1_Neuropathy,distal_hereditary_motor,type_VIIB,607641/Amyotrophic_lateral_sclerosis,susceptibility_to,105400/Perry_syndrome,168605]
chr2	74691613	74691859	3	4	1	   0.246	0.076	MOGS	0.04254				601336_[MOGS_Congenital_disorder_of_glycosylation,type_IIb,606056]
chr2	84676763	84686596	3	7	2	   9.833	0.096	SUCLG1	0.10226				611224_[SUCLG1_Mitochondrial_DNA_depletion_syndrome_9_(encephalomyopathic_type_with_methylmalonic_aciduria),245400]
chr2	97213129	97213264	3	17	1	   0.135	0.096	ARID5A	0.00039			ARID5A	
chr2	99179918	99181236	3	8	2	   1.318	0.083	INPP4A	0.03283				
chr2	109367710	109368169	3	7	2	   0.459	0.153	RANBP2	0.02518				601181_[RANBP2_Encephalopathy,acute,infection-induced,3,susceptibility_to,608033]
chr2	109522754	109527316	1	3	3	   4.562	0.089	EDAR	0.04579			EDAR	604095_[EDAR_Ectodermal_dysplasia_10A,hypohidrotic/hair/nail_type,autosomal_dominant,129490/Ectodermal_dysplasia_10B,hypohidrotic/hair/tooth_type,autosomal_recessive,224900/Hair_morphology_1,hair_thickness,612630]
chr2	110926019	110926140	3	4	1	   0.121	0.217	NPHP1	0.04579			NPHP1	607100_[NPHP1_Nephronophthisis_1,juvenile,256100/Senior-Loken_syndrome-1,266900/Joubert_syndrome_4,609583]
chr2	110962467	110962649	4	8	1	   0.182	0.236	NPHP1	0.01429			NPHP1	607100_[NPHP1_Nephronophthisis_1,juvenile,256100/Senior-Loken_syndrome-1,266900/Joubert_syndrome_4,609583]
chr2	113885128	113887251	3	3	2	   2.123	0.191	IL1RN	0.09143				147679_[IL1RN_Gastric_cancer_risk_after_H._pylori_infection,137215/Microvascular_complications_of_diabetes_4,612628/Interleukin_1_receptor_antagonist_deficiency,612852]
chr2	152422220	152422344	3	3	1	   0.124	0.006	NEB	0.03908				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152437301	152437428	3	5	1	   0.127	0.268	NEB	0.03348				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152458405	152458532	3	5	1	   0.127	0.261	NEB	0.03429				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152463110	152464132	3	3	2	   1.022	0.280	NEB	0.16914		yes		161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152521837	152522063	1	5	1	   0.226	0.331	NEB	0.03700				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152590902	152591011	3	5	1	   0.109	0.172	NEB	0.03052				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152739755	152739894	3	4	1	   0.139	0.032	CACNB4	0.02613			CACNB4	601949_[CACNB4_Epilepsy,juvenile_myoclonic,susceptibility_to,6,607682/Epilepsy,idiopathic_generalized,susceptibility_to,9,607682/Episodic_ataxia,type_5,613855]
chr2	166854538	166854695	1	4	1	   0.157	0.344	SCN1A	0.03109			SCN1A	182389_[SCN1A_Epilepsy,generalized,with_febrile_seizures_plus,type_2,604403/Migraine,familial_hemiplegic,3,609634/Febrile_seizures,familial,3A,604403/Epileptic_encephalopathy,early_infantile,6_(Dravet_syndrome),607208]
chr2	167232197	167232507	3	8	1	   0.310	0.102	SCN9A	0.00816				603415_[SCN9A_Erythermalgia,primary,133020/Paroxysmal_extreme_pain_disorder,167400,/Insensitivity_to_pain,congenital,243000/Febrile_seizures,familial,3B,613863/Epilepsy,generalized,with_febrile_seizures_plus,type_7,613863/Small_fiber_neuropathy,133020/Dravet_syndrome,modifier_of,607208/HSAN2D,autosomal_recessive,243000]
chr2	170151100	170151230	3	4	1	   0.130	0.121	LRP2	0.03272			LRP2	600073_[LRP2_Donnai-Barrow_syndrome,222448]
chr2	173330257	173330401	3	6	1	   0.144	0.178	ITGA6,ITGA6-AS1	0.02334				147556_[ITGA6_Epidermolysis_bullosa,junctional,with_pyloric_stenosis,226730]
chr2	179484705	179484849	3	7	1	   0.144	0.045	TTN,TTN-AS1	0.01240				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179546093	179546475	3	3	2	   0.382	0.242	TTN,TTN-AS1	0.12474				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179548716	179549486	3	4	3	   0.770	0.108	TTN,TTN-AS1	0.07967				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179556733	179558745	3	7	4	   2.012	0.229	TTN,TTN-AS1	0.10082				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179566885	179566982	3	4	1	   0.097	0.057	TTN,TTN-AS1	0.04030				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179571579	179571691	3	4	1	   0.112	0.032	TTN,TTN-AS1	0.03360				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179584271	179584569	3	4	1	   0.298	0.045	TTN,TTN-AS1	0.03391				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	190444529	190445547	3	9	2	   1.018	0.127	SLC40A1	0.00856				604653_[SLC40A1_Hemochromatosis,type_4,606069]
chr2	191843572	191843737	3	3	1	   0.165	0.191	STAT1	0.10493				600555_[STAT1_Immunodeficiency_31A,mycobacteriosis,autosomal_dominant,614892/Immunodeficiency_31B,mycobacterial_and_viral_infections,autosomal_recessive,613796/Immunodeficiency_31C,autosomal_dominant,614162]
chr2	191848358	191849129	3	3	2	   0.771	0.153	STAT1	0.07551				600555_[STAT1_Immunodeficiency_31A,mycobacteriosis,autosomal_dominant,614892/Immunodeficiency_31B,mycobacterial_and_viral_infections,autosomal_recessive,613796/Immunodeficiency_31C,autosomal_dominant,614162]
chr2	198363389	198363584	3	3	1	   0.195	0.236	HSPD1	0.09902				118190_[HSPD1_Spastic_paraplegia_13,autosomal_dominant,605280/Leukodystrophy,hypomyelinating,4,612233]
chr2	202568835	202569336	3	3	2	   0.501	0.076	ALS2	0.08833				606352_[ALS2_Amyotrophic_lateral_sclerosis_2,juvenile,205100/Primary_lateral_sclerosis,juvenile,606353/Spastic_paralysis,infantile_onset_ascending,607225]
chr2	204822512	204822616	3	4	1	   0.104	0.051	ICOS	0.02287				604558_[ICOS_Immunodeficiency,common_variable,1,607594]
chr2	207023810	207024253	3	6	2	   0.443	0.146	NDUFS1	0.01152				157655_[NDUFS1_Mitochondrial_complex_I_deficiency,nuclear_type_5,618226]
chr2	207636895	207637054	3	3	1	   0.159	0.032	FASTKD2	0.03215				612322_[FASTKD2_Mitochondrial_complex_IV_deficiency,220110]
chr2	211057518	211060072	3	8	2	   2.554	0.134	ACADL	0.05752				
chr2	211069295	211069416	3	3	1	   0.121	0.134	ACADL	0.07659				
chr2	211085361	211090225	3	4	2	   4.864	0.146	ACADL	0.07833				
chr2	217339982	217340184	3	7	1	   0.202	0.108	SMARCAL1	0.01282				606622_[SMARCAL1_Schimke_immunoosseous_dysplasia,242900]
chr2	227896854	227912275	3	12	5	  15.421	0.261	COL4A4	0.15389	yes			120131_[COL4A4_Alport_syndrome,autosomal_recessive,203780/Hematuria,familial_benign]
chr2	227920651	227924969	3	8	4	   4.318	0.248	COL4A4	0.14491				120131_[COL4A4_Alport_syndrome,autosomal_recessive,203780/Hematuria,familial_benign]
chr2	227973930	227983487	3	10	3	   9.557	0.146	COL4A4	0.03626				120131_[COL4A4_Alport_syndrome,autosomal_recessive,203780/Hematuria,familial_benign]
chr2	228135476	228137843	3	5	2	   2.367	0.223	COL4A3	0.11354			COL4A3	120070_[COL4A3_Alport_syndrome,autosomal_recessive,203780/Hematuria,benign_familial,141200/Alport_syndrome,autosomal_dominant,104200]
chr2	233398631	233398855	3	5	1	   0.224	0.083	CHRND	0.02442				100690_[CHRND_Myasthenic_syndrome,congenital,1A,slow-channel,601462/Myasthenic_syndrome,congenital,1B,fast-channel,608930/Multiple_pterygium_syndrome,lethal_type,253290],100720_[CHRND_Myasthenic_syndrome,congenital,3A,slow-channel,616321/Myasthenic_syndrome,congenital,3B,fast-channel,616322/Myasthenic_syndrome,congenital,3C,associated_with_acetylcholine_receptor_deficiency,616323/Multiple_pterygium_syndrome,lethal_type,253290]
chr2	238261155	238262056	3	8	2	   0.901	0.229	COL6A3	0.02968				120250_[COL6A3_Bethlem_myopathy_1,158810/Ullrich_congenital_muscular_dystrophy_1,254090/Dystonia_27,616411]
chr2	240024462	240024602	3	7	1	   0.140	0.191	HDAC4	0.01571			HDAC4	600430_[HDAC4_Chromosome_2q37_deletion_syndrome]
chr2	240048142	240048385	1	6	1	   0.243	0.070	HDAC4	0.01757			HDAC4	600430_[HDAC4_Chromosome_2q37_deletion_syndrome]
chr2	240098099	240111783	1	13	2	  13.684	0.070	HDAC4	0.01330			HDAC4	600430_[HDAC4_Chromosome_2q37_deletion_syndrome]
chr2	241528750	241528901	3	5	1	   0.151	0.045	CAPN10	0.02829				605286_[CAPN10_Diabetes_mellitus,noninsulin-dependent_1,601283]
chr3	4535022	4536200	3	19	2	   1.178	0.172	ITPR1	0.00156			ITPR1	147265_[ITPR1_Spinocerebellar_ataxia_15,606658/Spinocerebellar_ataxia_29,congenital_nonprogressive,117360/Gillespie_syndrome,206700]
chr3	4687256	4687422	3	4	1	   0.166	0.038	ITPR1	0.04030			ITPR1	147265_[ITPR1_Spinocerebellar_ataxia_15,606658/Spinocerebellar_ataxia_29,congenital_nonprogressive,117360/Gillespie_syndrome,206700]
chr3	4725060	4725245	3	5	1	   0.185	0.076	ITPR1	0.03611			ITPR1	147265_[ITPR1_Spinocerebellar_ataxia_15,606658/Spinocerebellar_ataxia_29,congenital_nonprogressive,117360/Gillespie_syndrome,206700]
chr3	12705302	12705710	3	6	1	   0.408	0.115	RAF1	0.02602	yes		RAF1	164760_[RAF1_Noonan_syndrome_5,611553/LEOPARD_syndrome_2,611554/Cardiomyopathy,dilated,1NN,615916]
chr3	24536133	24536323	1	7	1	   0.190	0.102	THRB,THRB-AS1	0.01571				190160_[THRB_Thyroid_hormone_resistance,188570/Thyroid_hormone_resistance,autosomal_recessive,274300/Thyroid_hormone_resistance,selective_pituitary,145650]
chr3	30715587	30730013	3	9	2	  14.426	0.102	TGFBR2	0.01277			TGFBR2	190182_[TGFBR2_Colorectal_cancer,hereditary_nonpolyposis,type_6,614331/Esophageal_cancer,somatic,133239/Loeys-Dietz_syndrome_2,610168]
chr3	38179959	38181499	3	5	2	   1.540	0.051	MYD88	0.00082				602170_[MYD88_Pyogenic_bacterial_infections,recurrent,due_to_MYD88_deficiency,612260/Macroglobulinemia,Waldenstrom,somatic,153600]
chr3	46620712	46620866	3	7	1	   0.154	0.102	LRRC2,TDGF1	0.01940			TDGF1	187395_[TDGF1_Forebrain_defects]
chr3	48604330	48604633	3	3	2	   0.303	0.070	COL7A1	0.04262				120120_[COL7A1_Epidermolysis_bullosa_dystrophica,AD,131750/Epidermolysis_bullosa_dystrophica,AR,226600/Epidermolysis_bullosa,pretibial,131850/EBD,Bart_type,132000/EBD,localisata_variant/Transient_bullous_of_the_newborn,131705/Epidermolysis_bullosa_pruriginosa,604129/Toenail_dystrophy,isolated,607523/EBD_inversa,226600]
chr3	48610597	48610679	3	4	1	   0.082	0.115	COL7A1	0.03758				120120_[COL7A1_Epidermolysis_bullosa_dystrophica,AD,131750/Epidermolysis_bullosa_dystrophica,AR,226600/Epidermolysis_bullosa,pretibial,131850/EBD,Bart_type,132000/EBD,localisata_variant/Transient_bullous_of_the_newborn,131705/Epidermolysis_bullosa_pruriginosa,604129/Toenail_dystrophy,isolated,607523/EBD_inversa,226600]
chr3	48613049	48616720	3	7	4	   3.671	0.057	COL7A1	0.05561				120120_[COL7A1_Epidermolysis_bullosa_dystrophica,AD,131750/Epidermolysis_bullosa_dystrophica,AR,226600/Epidermolysis_bullosa,pretibial,131850/EBD,Bart_type,132000/EBD,localisata_variant/Transient_bullous_of_the_newborn,131705/Epidermolysis_bullosa_pruriginosa,604129/Toenail_dystrophy,isolated,607523/EBD_inversa,226600]
chr3	48618683	48618783	3	3	1	   0.100	0.159	COL7A1	0.05414				120120_[COL7A1_Epidermolysis_bullosa_dystrophica,AD,131750/Epidermolysis_bullosa_dystrophica,AR,226600/Epidermolysis_bullosa,pretibial,131850/EBD,Bart_type,132000/EBD,localisata_variant/Transient_bullous_of_the_newborn,131705/Epidermolysis_bullosa_pruriginosa,604129/Toenail_dystrophy,isolated,607523/EBD_inversa,226600]
chr3	48625216	48625847	3	7	2	   0.631	0.197	COL7A1	0.03967				120120_[COL7A1_Epidermolysis_bullosa_dystrophica,AD,131750/Epidermolysis_bullosa_dystrophica,AR,226600/Epidermolysis_bullosa,pretibial,131850/EBD,Bart_type,132000/EBD,localisata_variant/Transient_bullous_of_the_newborn,131705/Epidermolysis_bullosa_pruriginosa,604129/Toenail_dystrophy,isolated,607523/EBD_inversa,226600]
chr3	48630525	48630706	3	5	1	   0.181	0.051	COL7A1	0.02112				120120_[COL7A1_Epidermolysis_bullosa_dystrophica,AD,131750/Epidermolysis_bullosa_dystrophica,AR,226600/Epidermolysis_bullosa,pretibial,131850/EBD,Bart_type,132000/EBD,localisata_variant/Transient_bullous_of_the_newborn,131705/Epidermolysis_bullosa_pruriginosa,604129/Toenail_dystrophy,isolated,607523/EBD_inversa,226600]
chr3	48936113	48936436	3	7	1	   0.323	0.166	SLC25A20	0.01367				613698_[SLC25A20_Carnitine-acylcarnitine_translocase_deficiency,212138]
chr3	49058608	49058842	3	4	1	   0.234	0.185	DALRD3,NDUFAF3	0.04189				612911_[NDUFAF3_Mitochondrial_complex_I_deficiency,nuclear_type_18,618240]
chr3	49459527	49459714	3	4	1	   0.187	0.038	AMT	0.01195				238310_[AMT_Glycine_encephalopathy,605899]
chr3	58062763	58063031	0	9	1	   0.268	0.369	FLNB	0.01920				603381_[FLNB_Spondylocarpotarsal_synostosis_syndrome,272460/Larsen_syndrome,150250/Atelosteogenesis,type_I,108720/Atelosteogenesis,type_III,108721/Boomerang_dysplasia,112310]
chr3	58110049	58111480	3	3	2	   1.431	0.242	FLNB	0.12418				603381_[FLNB_Spondylocarpotarsal_synostosis_syndrome,272460/Larsen_syndrome,150250/Atelosteogenesis,type_I,108720/Atelosteogenesis,type_III,108721/Boomerang_dysplasia,112310]
chr3	63953410	63968131	3	6	3	  14.721	0.070	ATXN7	0.03360				607640_[ATXN7_Spinocerebellar_ataxia_7,164500]
chr3	121553228	121553936	3	6	2	   0.708	0.210	IQCB1	0.03360				609237_[IQCB1_Senior-Loken_syndrome_5,609254]
chr3	128621386	128621481	1	7	1	   0.095	0.032	ACAD9	0.01385				611103_[ACAD9_Mitochondrial_complex_I_deficiency,nuclear_type_20,611126]
chr3	128629574	128629666	1	4	1	   0.092	0.121	ACAD9,KIAA1257	0.03058				611103_[ACAD9_Mitochondrial_complex_I_deficiency,nuclear_type_20,611126]
chr3	135969157	135969410	3	5	1	   0.253	0.185	PCCB	0.01449				232050_[PCCB_Propionicacidemia,606054]
chr3	139062851	139063050	5	19	1	   0.199	0.217	MRPS22	0.00008				605810_[MRPS22_Combined_oxidative_phosphorylation_deficiency_5,611719/Ovarian_dysgenesis_7,618117]
chr3	142297478	142297678	4	11	1	   0.200	0.185	ATR	0.00223			ATR	601215_[ATR_Seckel_syndrome_1,210600/Cutaneous_telangiectasia_and_cancer_syndrome,familial,614564]
chr3	155571002	158362514	3	9	2	2791.512	0.159	SLC33A1,GFM1	0.00506	yes	yes		603690_[SLC33A1_Spastic_paraplegia_42,autosomal_dominant,612539/Congenital_cataracts,hearing_loss,and_neurodegeneration,614482],601402_[MLF1_Leukemia,acute_myeloid,601626],606639_[GFM1_Combined_oxidative_phosphorylation_deficiency_1,609060]
chr3	180707110	180707572	3	14	2	   0.462	0.159	DNAJC19	0.00123				608977_[DNAJC19_3-methylglutaconic_aciduria,type_V,610198]
chr3	184072326	184072771	1	3	2	   0.445	0.127	CLCN2,EIF2B5	0.04062			CLCN2	603945_[EIF2B5_Leukoencephalopathy_with_vanishing_white_matter,603896/Ovarioleukodystrophy,603896],600570_[CLCN2_Epilepsy,juvenile_myoclonic,susceptibility_to,8,607628/Epilepsy,juvenile_absence,susceptibility_to,2,607628/Epilepsy,idiopathic_generalized,susceptibility_to,11,607628/Leukoencephalopathy_with_ataxia,615651/Hyperaldosteronism,familial,type_II,605635]
chr3	184074771	184074892	3	3	1	   0.121	0.070	CLCN2,EIF2B5	0.04282			CLCN2	603945_[EIF2B5_Leukoencephalopathy_with_vanishing_white_matter,603896/Ovarioleukodystrophy,603896],600570_[CLCN2_Epilepsy,juvenile_myoclonic,susceptibility_to,8,607628/Epilepsy,juvenile_absence,susceptibility_to,2,607628/Epilepsy,idiopathic_generalized,susceptibility_to,11,607628/Leukoencephalopathy_with_ataxia,615651/Hyperaldosteronism,familial,type_II,605635]
chr3	190039763	190040245	3	7	1	   0.482	0.121	CLDN1	0.01440				603718_[CLDN1_Ichthyosis,leukocyte_vacuoles,alopecia,and_sclerosing_cholangitis,607626]
chr3	197025279	197025457	3	4	1	   0.178	0.248	DLG1,DLG1-AS1	0.03978			DLG1	
chr3	197403746	197404422	3	2	2	   0.676	0.140	RUBCN	0.01940				613516_[RUBCN_Spinocerebellar_ataxia,autosomal_recessive_15,615705]
chr3	197410168	197410320	4	4	1	   0.152	0.229	RUBCN	0.05410				613516_[RUBCN_Spinocerebellar_ataxia,autosomal_recessive_15,615705]
chr3	197444838	197476578	3	7	2	  31.740	0.121	RUBCN,FYTTD1	0.02366				613516_[RUBCN_Spinocerebellar_ataxia,autosomal_recessive_15,615705]
chr4	994390	997910	1	11	7	   3.520	0.038	IDUA	0.09196				252800_[IDUA_Mucopolysaccharidosis_Ih,607014/Mucopolysaccharidosis_Is,607016/Mucopolysaccharidosis_Ih/s,607015]
chr4	1803084	1804801	1	2	4	   1.717	0.083	FGFR3	0.21328			FGFR3	134934_[FGFR3_Achondroplasia,100800/Hypochondroplasia,146000/Thanatophoric_dysplasia,type_I,187600/Crouzon_syndrome_with_acanthosis_nigricans,612247/Muenke_syndrome,602849/Bladder_cancer,somatic,109800/Colorectal_cancer,somatic,114500/Cervical_cancer,somatic,603956/LADD_syndrome,149730/CATSHL_syndrome,610474/Nevus,epidermal,somatic,162900/Thanatophoric_dysplasia,type_II,187601/Spermatocytic_seminoma,somatic,273300/SADDAN,616482]
chr4	1807072	1807406	1	3	2	   0.334	0.338	FGFR3	0.16031			FGFR3	134934_[FGFR3_Achondroplasia,100800/Hypochondroplasia,146000/Thanatophoric_dysplasia,type_I,187600/Crouzon_syndrome_with_acanthosis_nigricans,612247/Muenke_syndrome,602849/Bladder_cancer,somatic,109800/Colorectal_cancer,somatic,114500/Cervical_cancer,somatic,603956/LADD_syndrome,149730/CATSHL_syndrome,610474/Nevus,epidermal,somatic,162900/Thanatophoric_dysplasia,type_II,187601/Spermatocytic_seminoma,somatic,273300/SADDAN,616482]
chr4	1900938	1901132	3	6	1	   0.194	0.166	NSD2	0.02387			NSD2	
chr4	1953825	1953968	3	4	1	   0.143	0.159	NSD2	0.05775			NSD2	
chr4	1957410	1957586	3	4	1	   0.176	0.204	NSD2	0.07382			NSD2	
chr4	15471479	15471691	3	6	1	   0.212	0.166	CC2D2A	0.01642			CC2D2A	612013_[CC2D2A_Joubert_syndrome_9,612285/Meckel_syndrome_6,612284/COACH_syndrome,216360]
chr4	79207549	79207703	3	3	1	   0.154	0.064	FRAS1	0.03700				607830_[FRAS1_Fraser_syndrome_1,219000]
chr4	79440475	79440645	3	4	1	   0.170	0.204	FRAS1	0.06827				607830_[FRAS1_Fraser_syndrome_1,219000]
chr4	87653543	87653637	3	4	1	   0.094	0.019	PTPN13	0.03000				
chr4	87679821	87679948	3	4	1	   0.127	0.172	PTPN13	0.06009				
chr4	87696314	87696505	3	6	1	   0.191	0.166	PTPN13	0.02934				
chr4	103681865	107237761	3	16	3	3555.896	0.153	MANBA,AIMP1,TBCK	0.01450	yes	yes		609489_[MANBA_Mannosidosis,beta,248510],611507_[CISD2_Wolfram_syndrome_2,604928],117143_[CENPE_Microcephaly_13,primary,autosomal_recessive,616051],162332_[TACR3_Hypogonadotropic_hypogonadism_11_with_or_without_anosmia,614840],612839_[TET2_Myelodysplastic_syndrome,somatic,614286],609988_[PPA2_Sudden_cardiac_failure,infantile,617222/Sudden_cardiac_failure,alcohol-induced,617223],616899_[TBCK_Hypotonia,infantile,with_psychomotor_retardation_and_characteristic_facies_3,616900],603605_[AIMP1_Leukodystrophy,hypomyelinating,3,260600]
chr4	113567497	113567617	1	5	1	   0.120	0.032	LARP7	0.02442				612026_[LARP7_Alazami_syndrome,615071]
chr4	119239523	119253031	3	3	2	  13.508	0.217	PRSS12	0.08439				606709_[PRSS12_Mental_retardation,autosomal_recessive_1,249500]
chr4	122791423	122791662	4	4	1	   0.239	0.248	BBS7	0.02866				607590_[BBS7_Bardet-Biedl_syndrome_7,615984]
chr4	128886217	128887149	3	4	2	   0.932	0.197	MFSD8,ABHD18	0.05775				611124_[MFSD8_Ceroid_lipofuscinosis,neuronal,7,610951/Macular_dystrophy_with_central_cone_involvement,616170]
chr4	148601464	148605290	3	6	2	   3.826	0.096	PRMT9	0.00895				
chr4	184365779	184366232	3	4	1	   0.453	0.121	CDKN2AIP	0.04132				
chr5	254498	254631	3	6	1	   0.133	0.057	SDHA	0.01385				600857_[SDHA_Leigh_syndrome,256000/Mitochondrial_respiratory_chain_complex_II_deficiency,252011/Cardiomyopathy,dilated,1GG,613642/Paragangliomas_5,614165]
chr5	1416203	1420828	3	7	2	   4.625	0.108	SLC6A3	0.01312				126455_[SLC6A3_Nicotine_dependence,protection_against,188890/Parkinsonism-dystonia,infantile,1,613135]
chr5	6632987	6633483	4	7	1	   0.496	0.172	NSUN2,SRD5A1	0.01277				610916_[NSUN2_Mental_retardation,autosomal_recessive_5,611091]
chr5	11346474	11565178	3	5	4	 218.704	0.217	CTNND2	0.10777			CTNND2	
chr5	11903919	11904120	1	5	1	   0.201	0.376	CTNND2	0.14839			CTNND2	
chr5	35856981	35857171	3	3	1	   0.190	0.076	IL7R	0.01843				146661_[IL7R_Severe_combined_immunodeficiency,T-cell_negative,B-cell/natural_killer_cell-positive_type,608971]
chr5	36876851	36953872	3	4	2	  77.021	0.140	NIPBL	0.06442			NIPBL	608667_[NIPBL_Cornelia_de_Lange_syndrome_1,122470]
chr5	38489170	38489357	3	3	1	   0.187	0.223	LIFR	0.08114				151443_[LIFR_Stuve-Wiedemann_syndrome/Schwartz-Jampel_type_2_syndrome,601559]
chr5	52404342	52856600	3	8	3	 452.258	0.166	MOCS2,NDUFS4	0.02070	yes			603708_[MOCS2_Molybdenum_cofactor_deficiency_B,252160],602694_[NDUFS4_Mitochondrial_complex_I_deficiency,nuclear_type_1,252010]
chr5	74012402	74012508	3	3	1	   0.106	0.070	HEXB	0.02988			HEXB	606873_[HEXB_Sandhoff_disease,infantile,juvenile,and_adult_forms,268800]
chr5	77406021	77412068	3	3	3	   6.047	0.223	AP3B1	0.13565				603401_[AP3B1_Hermansky-Pudlak_syndrome_2,608233]
chr5	78280750	78282367	3	4	1	   1.617	0.217	ARSB	0.02366				611542_[ARSB_Mucopolysaccharidosis_type_VI_(Maroteaux-Lamy),253200]
chr5	88056795	88179293	3	6	5	 122.498	0.096	MEF2C,MEF2C-AS1	0.02882			MEF2C	600662_[MEF2C_Mental_retardation,stereotypic_movements,epilepsy,and/or_cerebral_malformations,613443/Chromosome_5q14.3_deletion_syndrome,613443]
chr5	90098546	90098709	3	7	1	   0.163	0.121	ADGRV1	0.01450			ADGRV1	602851_[ADGRV1_Febrile_seizures,familial,4,604352/Usher_syndrome,type_2C,605472/Usher_syndrome,type_2C,GPR98/PDZD7_digenic,605472]
chr5	127641193	127641650	3	1	2	   0.457	0.032	FBN2	0.03111				612570_[FBN2_Contractural_arachnodactyly,congenital,121050/Macular_degeneration,early-onset,616118]
chr5	131892606	131893155	3	4	1	   0.549	0.172	RAD50	0.04414				604040_[RAD50_Nijmegen_breakage_syndrome-like_disorder,613078]
chr5	131972797	131972902	1	5	1	   0.105	0.070	RAD50	0.02613				604040_[RAD50_Nijmegen_breakage_syndrome-like_disorder,613078]
chr5	132202309	132202737	3	14	2	   0.428	0.121	GDF9,UQCRQ	0.01144				601918_[GDF9_Premature_ovarian_failure_14,618014],612080_[UQCRQ_Mitochondrial_complex_III_deficiency,nuclear_type_4,615159]
chr5	138609431	138609860	4	17	1	   0.429	0.172	MATR3	0.00026				164015_[MATR3_Amyotrophic_lateral_sclerosis_21,606070]
chr5	138629323	138629727	4	9	1	   0.404	0.217	MATR3	0.00424				164015_[MATR3_Amyotrophic_lateral_sclerosis_21,606070]
chr5	140026831	140026957	3	4	1	   0.126	0.096	NDUFA2	0.05315				602137_[NDUFA2_Mitochondrial_complex_I_deficiency,nuclear_type_13,618235]
chr5	146460612	146461043	3	11	2	   0.431	0.025	PPP2R2B	0.00264				604325_[PPP2R2B_Spinocerebellar_ataxia_12,604326]
chr5	149912497	149912604	1	5	1	   0.107	0.070	NDST1	0.03497				600853_[NDST1_Mental_retardation,autosomal_recessive_46,616116]
chr5	150632603	150632868	3	7	1	   0.265	0.134	GM2A	0.00844				613109_[GM2A_GM2-gangliosidosis,AB_variant,272750]
chr5	156607897	156608136	3	6	1	   0.239	0.089	ITK	0.02297				186973_[ITK_Lymphoproliferative_syndrome_1,613011]
chr5	156638288	156638389	3	4	1	   0.101	0.045	ITK	0.01768				186973_[ITK_Lymphoproliferative_syndrome_1,613011]
chr5	156675850	156676027	3	4	1	   0.177	0.108	ITK	0.01920				186973_[ITK_Lymphoproliferative_syndrome_1,613011]
chr5	161275532	161275628	1	5	1	   0.096	0.166	GABRA1	0.03360			GABRA1	137160_[GABRA1_Epilepsy,juvenile_myoclonic,susceptibility_to,5,611136/Epilepsy,childhood_absence,susceptibility_to,4,611136/Epileptic_encephalopathy,early_infantile,19,615744]
chr5	172661743	172662325	1	4	1	   0.582	0.255	NKX2-5	0.04096			NKX2-5	600584_[NKX2-5_Atrial_septal_defect_7,with_or_without_AV_conduction_defects,108900/Tetralogy_of_Fallot,187500/Hypothyroidism,congenital_nongoitrous,5,225250/Ventricular_septal_defect_3,614432/Hypoplastic_left_heart_syndrome_2,614435/Conotruncal_heart_malformations,variable,217095]
chr6	31991697	31992439	1	2	3	   0.742	0.140	C4B	0.13947	yes	yes	C4B	120820_[C4B_C4B_deficiency,614379]
chr6	32805304	32806024	3	5	2	   0.720	0.134	TAP2	0.02682				170261_[TAP2_Bare_lymphocyte_syndrome,type_I,due_to_TAP2_deficiency,604571]
chr6	32819876	32820289	3	11	2	   0.413	0.051	PSMB9,TAP1	0.00014				177045_[PSMB9_Proteasome-associated_autoinflammatory_syndrome_3,digenic,617591],170260_[TAP1_Bare_lymphocyte_syndrome,type_I,604571]
chr6	33280984	33281651	3	2	2	   0.667	0.191	TAPBP	0.05775				601962_[TAPBP_Bare_lymphocyte_syndrome,type_I,604571]
chr6	35427449	35427547	1	4	1	   0.098	0.057	FANCE	0.04421				613976_[FANCE_Fanconi_anemia,complementation_group_E,600901]
chr6	39880626	39880758	1	4	1	   0.132	0.032	MOCS1	0.01768				603707_[MOCS1_Molybdenum_cofactor_deficiency_A,252150]
chr6	43543868	43544187	3	8	1	   0.319	0.089	POLH	0.01367				603968_[POLH_Xeroderma_pigmentosum,variant_type,278750]
chr6	52925724	52925854	3	7	1	   0.130	0.089	ICK	0.01463				612325_[ICK_Endocrine-cerebroosteodysplasia,612651/Epilepsy,juvenile_myoclonic,susceptibility_to,10,617924]
chr6	57072416	57072521	3	3	1	   0.105	0.038	RAB23	0.02518				606144_[RAB23_Carpenter_syndrome,201000]
chr6	88234265	88234380	3	5	1	   0.115	0.210	RARS2	0.03312				611524_[RARS2_Pontocerebellar_hypoplasia,type_6,611523]
chr6	88299630	88299745	3	4	1	   0.115	0.172	RARS2	0.04262				611524_[RARS2_Pontocerebellar_hypoplasia,type_6,611523]
chr6	100841353	100868844	3	8	2	  27.491	0.255	SIM1	0.15127			SIM1	603128_[SIM1_Obesity,severe,601665]
chr6	100897229	100897581	1	3	2	   0.352	0.172	SIM1	0.07839			SIM1	603128_[SIM1_Obesity,severe,601665]
chr6	100964046	100966028	3	7	2	   1.982	0.070	ASCC3	0.03262				
chr6	101846851	101847278	1	3	1	   0.427	0.229	GRIK2	0.05715			GRIK2	138244_[GRIK2_Mental_retardation,autosomal_recessive,6,611092]
chr6	107780184	107780789	3	7	1	   0.605	0.096	PDSS2	0.01571				610564_[PDSS2_Coenzyme_Q10_deficiency,primary,3,614652]
chr6	110012414	110012714	3	5	1	   0.300	0.204	AK9,FIG4	0.02518				609390_[FIG4_Charcot-Marie-Tooth_disease,type_4J,611228/Amyotrophic_lateral_sclerosis_11,612577/Yunis-Varon_syndrome,216340/Polymicrogyria,bilateral_temporooccipital,612691]
chr6	152557942	152558093	3	4	1	   0.151	0.178	SYNE1	0.04988				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	152622994	152623208	3	6	1	   0.214	0.146	SYNE1	0.01891				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	152639988	152640160	3	3	1	   0.172	0.032	SYNE1	0.02740				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	152763200	152763390	3	3	1	   0.190	0.166	SYNE1	0.08332				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	157222500	157222669	3	5	1	   0.169	0.159	ARID1B	0.03263			ARID1B	614556_[ARID1B_Coffin-Siris_syndrome_1,135900]
chr6	157431596	157431705	4	8	1	   0.109	0.280	ARID1B	0.01144			ARID1B	614556_[ARID1B_Coffin-Siris_syndrome_1,135900]
chr6	157488164	157488329	3	4	1	   0.165	0.096	ARID1B	0.02842			ARID1B	614556_[ARID1B_Coffin-Siris_syndrome_1,135900]
chr6	161152767	161152935	3	4	1	   0.168	0.070	PLG	0.03866				173350_[PLG_Dysplasminogenemia,217090/Plasminogen_deficiency,type_I,217090]
chr7	73461016	73461107	4	4	1	   0.091	0.293	ELN	0.07715			ELN	130160_[ELN_Supravalvar_aortic_stenosis,185500/Cutis_laxa,autosomal_dominant,123700],194050_[ELN_Williams-Beuren_syndrome]
chr7	73474696	73474841	1	5	1	   0.145	0.045	ELN,ELN-AS1	0.01707			ELN	130160_[ELN_Supravalvar_aortic_stenosis,185500/Cutis_laxa,autosomal_dominant,123700],194050_[ELN_Williams-Beuren_syndrome]
chr7	74203373	74203669	4	4	1	   0.296	0.191	NCF1,STAG3L2	0.03323			NCF1	608512_[NCF1_Chronic_granulomatous_disease_due_to_deficiency_of_NCF-1,233700]
chr7	94029498	94052440	3	19	10	  22.942	0.178	COL1A2	0.11223			COL1A2	120160_[COL1A2_Ehlers-Danlos_syndrome,arthrochalasia_type,2,617821/Osteogenesis_imperfecta,type_IV,166220/Osteogenesis_imperfecta,type_III,259420/Osteogenesis_imperfecta,type_II,166210/Osteoporosis,postmenopausal,166710/Ehlers-Danlos_syndrome,cardiac_valvular_type,225320]
chr7	99701022	99701152	1	4	1	   0.130	0.191	AP4M1	0.05134				602296_[AP4M1_Spastic_paraplegia_50,autosomal_recessive,612936]
chr7	103191504	103191753	4	5	1	   0.249	0.280	RELN	0.04062			RELN	600514_[RELN_Lissencephaly_2_(Norman-Roberts_type),257320/Epilepsy,familial_temporal_lobe,7,616436]
chr7	103202250	103202410	3	4	1	   0.160	0.108	RELN	0.05074			RELN	600514_[RELN_Lissencephaly_2_(Norman-Roberts_type),257320/Epilepsy,familial_temporal_lobe,7,616436]
chr7	127958000	127958169	3	3	1	   0.169	0.159	RBM28	0.06193				612074_[RBM28_Alopecia,neurologic_defects,and_endocrinopathy_syndrome,612079]
chr7	127983720	127983972	4	8	1	   0.252	0.287	RBM28	0.01152				612074_[RBM28_Alopecia,neurologic_defects,and_endocrinopathy_syndrome,612079]
chr7	128477681	128477819	3	4	1	   0.138	0.064	FLNC	0.03156	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	128480878	128481034	1	9	1	   0.156	0.025	FLNC	0.00662	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	128487989	128488132	1	3	1	   0.143	0.299	FLNC	0.05715	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	128495243	128495378	1	8	1	   0.135	0.274	FLNC	0.00978	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	142997006	142997154	3	10	1	   0.148	0.070	CASP2	0.00848				
chr7	143029807	143036425	3	4	2	   6.618	0.102	CLCN1	0.12455			CLCN1	118425_[CLCN1_Myotonia_congenita,recessive,255700/Myotonia_congenita,dominant,160800/Myotonia_levior,recessive]
chr7	148080731	148080990	3	3	1	   0.259	0.274	CNTNAP2	0.07702			CNTNAP2	604569_[CNTNAP2_Cortical_dysplasia-focal_epilepsy_syndrome,610042/Autism_susceptibility_15,612100/Pitt-Hopkins_like_syndrome_1,610042]
chr8	1814682	1814778	3	4	1	   0.096	0.178	ARHGEF10	0.04262				608136_[ARHGEF10_Slowed_nerve_conduction_velocity,AD,608236]
chr8	1900861	1901003	3	3	1	   0.142	0.083	ARHGEF10	0.05221				608136_[ARHGEF10_Slowed_nerve_conduction_velocity,AD,608236]
chr8	24812976	24814141	1	5	1	   1.165	0.076	NEFL	0.02682				162280_[NEFL_Charcot-Marie-Tooth_disease,type_2E,607684/Charcot-Marie-Tooth_disease,type_1F,607734/Charcot-Marie-Tooth_disease,dominant_intermediate_G,617882]
chr8	33367254	33367460	3	3	1	   0.206	0.102	TTI2	0.05412				614426_[TTI2_Mental_retardation,autosomal_recessive_39,615541]
chr8	38003471	38003675	3	5	1	   0.204	0.038	STAR	0.01920				600617_[STAR_Lipoid_adrenal_hyperplasia,201710]
chr8	38008263	38008610	3	5	1	   0.347	0.261	STAR	0.02270				600617_[STAR_Lipoid_adrenal_hyperplasia,201710]
chr8	43024306	43025847	3	6	2	   1.541	0.076	HGSNAT	0.03058				610453_[HGSNAT_Mucopolysaccharidosis_type_IIIC_(Sanfilippo_C),252930/Retinitis_pigmentosa_73,616544]
chr8	43048890	43048996	3	8	1	   0.106	0.051	HGSNAT	0.01429				610453_[HGSNAT_Mucopolysaccharidosis_type_IIIC_(Sanfilippo_C),252930/Retinitis_pigmentosa_73,616544]
chr8	48734155	48734363	3	3	1	   0.208	0.217	PRKDC	0.08850				600899_[PRKDC_Immunodeficiency_26,with_or_without_neurologic_abnormalities,615966]
chr8	61192238	61192449	3	5	1	   0.211	0.306	CA8	0.04018				114815_[CA8_Cerebellar_ataxia_and_mental_retardation_with_or_without_quadrupedal_locomotion_3,613227]
chr8	90955471	90958533	3	5	2	   3.062	0.051	NBN	0.00964				602667_[NBN_Nijmegen_breakage_syndrome,251260/Aplastic_anemia,609135/Leukemia,acute_lymphoblastic,613065]
chr8	94767062	94768104	3	10	2	   1.042	0.197	TMEM67	0.18069				609884_[TMEM67_Meckel_syndrome_3,607361/Joubert_syndrome_6,610688/Bardet-Biedl_syndrome_14,modifier_of,615991/COACH_syndrome,216360/Nephronophthisis_11,613550/RHYNS_syndrome,602152]
chr8	94929982	94930183	3	5	1	   0.201	0.178	PDP1	0.02038				605993_[PDP1_Pyruvate_dehydrogenase_phosphatase_deficiency,608782]
chr8	97245374	97246774	3	9	2	   1.400	0.172	UQCRB	0.03449				191330_[UQCRB_Mitochondrial_complex_III_deficiency,nuclear_type_3,615158]
chr8	100830669	100831126	3	3	2	   0.457	0.038	VPS13B	0.01920			VPS13B	607817_[VPS13B_Cohen_syndrome,216550]
chr8	100871522	100871718	4	4	1	   0.196	0.223	VPS13B	0.05619			VPS13B	607817_[VPS13B_Cohen_syndrome,216550]
chr8	120831576	120845084	3	10	2	  13.508	0.153	TAF2	0.01450				604912_[TAF2_Mental_retardation,autosomal_recessive_40,615599]
chr8	126044473	126044646	3	4	1	   0.173	0.076	WASHC5	0.04992				610657_[WASHC5_Spastic_paraplegia_8,autosomal_dominant,603563/Ritscher-Schinzel_syndrome_1,220210]
chr8	133895049	133895254	3	7	1	   0.205	0.102	TG	0.01843				188450_[TG_Thyroid_dyshormonogenesis_3,274700/Autoimmune_thyroid_disease,susceptibility_to,3,608175],610931_[TG_Autoimmune_thyroid_disease,susceptibility_to,3,608175]
chr8	133909884	133910041	3	7	1	   0.157	0.121	TG	0.01707				188450_[TG_Thyroid_dyshormonogenesis_3,274700/Autoimmune_thyroid_disease,susceptibility_to,3,608175],610931_[TG_Autoimmune_thyroid_disease,susceptibility_to,3,608175]
chr8	133920421	133920595	3	5	1	   0.174	0.102	TG	0.04062				188450_[TG_Thyroid_dyshormonogenesis_3,274700/Autoimmune_thyroid_disease,susceptibility_to,3,608175],610931_[TG_Autoimmune_thyroid_disease,susceptibility_to,3,608175]
chr8	140714943	140715309	1	7	1	   0.366	0.242	KCNK9	0.01920			KCNK9	605874_[KCNK9_Birk-Barel_mental_retardation_dysmorphism_syndrome,612292]
chr8	140744212	140898223	4	8	2	 154.011	0.210	TRAPPC9	0.04030	yes			611966_[TRAPPC9_Mental_retardation,autosomal_recessive_13,613192]
chr8	141297697	141297843	3	7	1	   0.146	0.089	TRAPPC9	0.02459				611966_[TRAPPC9_Mental_retardation,autosomal_recessive_13,613192]
chr8	141468370	141468688	3	4	1	   0.318	0.166	TRAPPC9	0.04424				611966_[TRAPPC9_Mental_retardation,autosomal_recessive_13,613192]
chr8	145006558	145007529	1	3	4	   0.971	0.121	PLEC	0.02271				601282_[PLEC_Epidermolysis_bullosa_simplex_with_muscular_dystrophy,226670/Epidermolysis_bullosa_simplex,Ogna_type,131950/Epidermolysis_bullosa_simplex_with_pyloric_atresia,612138/Muscular_dystrophy,limb-girdle,autosomal_recessive_17,613723/Epidermolysis_bullosa_simplex_with_nail_dystrophy,616487]
chr8	145008156	145008623	4	17	2	   0.467	0.083	PLEC	0.00223				601282_[PLEC_Epidermolysis_bullosa_simplex_with_muscular_dystrophy,226670/Epidermolysis_bullosa_simplex,Ogna_type,131950/Epidermolysis_bullosa_simplex_with_pyloric_atresia,612138/Muscular_dystrophy,limb-girdle,autosomal_recessive_17,613723/Epidermolysis_bullosa_simplex_with_nail_dystrophy,616487]
chr8	145009169	145011249	1	7	4	   2.080	0.191	PLEC	0.10522				601282_[PLEC_Epidermolysis_bullosa_simplex_with_muscular_dystrophy,226670/Epidermolysis_bullosa_simplex,Ogna_type,131950/Epidermolysis_bullosa_simplex_with_pyloric_atresia,612138/Muscular_dystrophy,limb-girdle,autosomal_recessive_17,613723/Epidermolysis_bullosa_simplex_with_nail_dystrophy,616487]
chr9	286451	289591	3	4	2	   3.140	0.217	DOCK8	0.10592	yes			611432_[DOCK8_Hyper-IgE_recurrent_infection_syndrome,autosomal_recessive,243700]
chr9	470284	470384	6	44	1	   0.100	0.191	KANK1	0.00000			KANK1	607704_[KANK1_Cerebral_palsy,spastic_quadriplegic,2,612900]
chr9	2073202	2073352	3	5	1	   0.150	0.025	SMARCA2	0.01768				600014_[SMARCA2_Nicolaides-Baraitser_syndrome,601358]
chr9	34646625	34647968	3	13	4	   1.343	0.057	GALT	0.00737				606999_[GALT_Galactosemia,230400]
chr9	35079138	35658025	4	6	3	 578.887	0.121	FANCG,RMRP	0.06097	yes	yes		602956_[FANCG_Fanconi_anemia,complementation_group_G,614082],614730_[PIGO_Hyperphosphatasia_with_mental_retardation_syndrome_2,614749],611053_[RUSC2_Mental_retardation,autosomal_recessive_61,617773],157660_[RMRP_Cartilage-hair_hypoplasia,250250/Metaphyseal_dysplasia_without_hypotrichosis,250460/Anauxetic_dysplasia_1,607095]
chr9	35684719	35684814	1	3	1	   0.095	0.051	TPM2	0.03442				190990_[TPM2_Arthrogryposis_multiplex_congenita,distal,type_1,108120/Arthrogryposis,distal,type_2B,601680/Nemaline_myopathy_4,autosomal_dominant,609285/CAP_myopathy_2,609285]
chr9	94871012	94871126	3	3	1	   0.114	0.229	SPTLC1	0.07656				605712_[SPTLC1_Neuropathy,hereditary_sensory_and_autonomic,type_IA,162400]
chr9	98270206	98270332	1	4	1	   0.126	0.045	PTCH1	0.03623			PTCH1	601309_[PTCH1_Basal_cell_nevus_syndrome,109400/Basal_cell_carcinoma,somatic,605462/Holoprosencephaly_7,610828]
chr9	111651602	111651683	3	10	1	   0.081	0.108	ELP1	0.00737				603722_[ELP1_Dysautonomia,familial,223900]
chr9	123342188	123342447	3	4	1	   0.259	0.287	CDK5RAP2	0.04322				608201_[CDK5RAP2_Microcephaly_3,primary,autosomal_recessive,604804]
chr9	123737047	123737219	3	3	1	   0.172	0.025	C5	0.01973				120900_[C5_C5_deficiency,609536/Eculizumab,poor_response_to,615749]
chr9	123744112	123744227	3	5	1	   0.115	0.076	C5	0.02011				120900_[C5_C5_deficiency,609536/Eculizumab,poor_response_to,615749]
chr9	124062324	124062414	1	5	1	   0.090	0.229	GSN	0.04041				137350_[GSN_Amyloidosis,Finnish_type,105120]
chr9	124065179	124065353	3	5	1	   0.174	0.191	GSN	0.03498				137350_[GSN_Amyloidosis,Finnish_type,105120]
chr9	124080674	124081168	1	2	2	   0.494	0.096	GSN	0.03360				137350_[GSN_Amyloidosis,Finnish_type,105120]
chr9	127265348	129377858	1	7	4	2112.510	0.223	NR5A1,LMX1B	0.07178	yes	yes	NR5A1,LMX1B	184757_[NR5A1_46XY_sex_reversal_3,612965/Premature_ovarian_failure_7,612964/Adrenocortical_insufficiency,612964/46,XX_sex_reversal_4,617480/Spermatogenic_failure_8,613957],602575_[LMX1B_Nail-patella_syndrome,161200]
chr9	130425474	130425642	3	3	1	   0.168	0.229	STXBP1	0.08833			STXBP1	602926_[STXBP1_Epileptic_encephalopathy,early_infantile,4,612164]
chr9	130700087	131267193	3	20	2	 567.106	0.121	DPM2,GLE1	0.00003	yes			603564_[DPM2_Congenital_disorder_of_glycosylation,type_Iu,615042],602377_[DNM1_Epileptic_encephalopathy,early_infantile,31,616346],612898_[COQ4_Coenzyme_Q10_deficiency,primary,7,616276],604194_[SLC27A4_Ichthyosis_prematurity_syndrome,608649],603371_[GLE1_Lethal_congenital_contracture_syndrome_1,253310/Arthrogryposis,lethal,with_anterior_horn_cell_disease,611890]
chr9	131289725	131289814	1	3	1	   0.089	0.096	GLE1	0.01429				603371_[GLE1_Lethal_congenital_contracture_syndrome_1,253310/Arthrogryposis,lethal,with_anterior_horn_cell_disease,611890]
chr9	131367565	131367766	3	4	1	   0.201	0.032	SPTAN1	0.05329				182810_[SPTAN1_Epileptic_encephalopathy,early_infantile,5,613477]
chr9	131644771	131645198	3	8	1	   0.427	0.102	LRRC8A	0.00874				608360_[LRRC8A_Agammaglobulinemia_5,613506]
chr9	134386714	134386864	3	3	1	   0.150	0.134	POMT1	0.08439			POMT1	607423_[POMT1_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,1,236670/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,1,613155/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,1,609308]
chr9	135152437	135152549	1	4	1	   0.112	0.382	SETX	0.26771				608465_[SETX_Amyotrophic_lateral_sclerosis_4,juvenile,602433/Spinocerebellar_ataxia,autosomal_recessive_1,606002]
chr9	135206429	135206536	3	6	1	   0.107	0.019	SETX	0.01843				608465_[SETX_Amyotrophic_lateral_sclerosis_4,juvenile,602433/Spinocerebellar_ataxia,autosomal_recessive_1,606002]
chr9	135218067	135218196	3	3	1	   0.129	0.146	SETX	0.07625				608465_[SETX_Amyotrophic_lateral_sclerosis_4,juvenile,602433/Spinocerebellar_ataxia,autosomal_recessive_1,606002]
chr9	135786830	135786965	3	4	1	   0.135	0.185	TSC1	0.04557			TSC1	605284_[TSC1_Tuberous_sclerosis-1,191100/Lymphangioleiomyomatosis,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr9	135977853	135977968	1	4	1	   0.115	0.064	RALGDS	0.03348				
chr9	139090488	139091736	1	4	2	   1.248	0.051	LHX3	0.03659				600577_[LHX3_Pituitary_hormone_deficiency,combined,3,221750]
chr9	139262079	139262290	1	3	1	   0.211	0.172	CARD9	0.04132				607212_[CARD9_Candidiasis,familial,2,autosomal_recessive,212050]
chr9	140674077	140674179	1	4	1	   0.102	0.280	EHMT1	0.06365			EHMT1	607001_[EHMT1_Kleefstra_syndrome_1,610253]
chr9	140707448	140707635	3	5	1	   0.187	0.204	EHMT1	0.05134			EHMT1	607001_[EHMT1_Kleefstra_syndrome_1,610253]
chr10	6104041	6104343	3	6	1	   0.302	0.178	IL2RA	0.02238				147730_[IL2RA_Immunodeficiency_41_with_lymphoproliferation_and_autoimmunity,606367/Diabetes,mellitus,insulin-dependent,susceptibility_to,10,601942]
chr10	43607537	43607682	1	12	1	   0.145	0.057	RET	0.00498			RET	164761_[RET_Multiple_endocrine_neoplasia_IIA,171400/Medullary_thyroid_carcinoma,155240/Multiple_endocrine_neoplasia_IIB,162300/Central_hypoventilation_syndrome,congenital,209880/Pheochromocytoma,171300/Hirschsprung_disease,susceptibility_to,1,142623/Hirschsprung_disease,protection_against,142623]
chr10	43615519	43615661	1	3	1	   0.142	0.051	RET	0.05715			RET	164761_[RET_Multiple_endocrine_neoplasia_IIA,171400/Medullary_thyroid_carcinoma,155240/Multiple_endocrine_neoplasia_IIB,162300/Central_hypoventilation_syndrome,congenital,209880/Pheochromocytoma,171300/Hirschsprung_disease,susceptibility_to,1,142623/Hirschsprung_disease,protection_against,142623]
chr10	50857544	50857692	3	5	1	   0.148	0.159	CHAT	0.03310			CHAT	118490_[CHAT_Myasthenic_syndrome,congenital,6,presynaptic,254210]
chr10	50863131	50863292	3	4	1	   0.161	0.038	CHAT	0.02667			CHAT	118490_[CHAT_Myasthenic_syndrome,congenital,6,presynaptic,254210]
chr10	73375251	73375383	1	6	1	   0.132	0.045	CDH23	0.01118				605516_[CDH23_Usher_syndrome,type_1D,601067/Deafness,autosomal_recessive_12,601386/Usher_syndrome,type_1D/F_digenic,601067/Pituitary_adenoma_5,multiple_types,617540]
chr10	73439134	73439259	1	4	1	   0.125	0.115	CDH23	0.05988				605516_[CDH23_Usher_syndrome,type_1D,601067/Deafness,autosomal_recessive_12,601386/Usher_syndrome,type_1D/F_digenic,601067/Pituitary_adenoma_5,multiple_types,617540]
chr10	73555518	73555846	1	4	1	   0.328	0.019	CDH23	0.02112				605516_[CDH23_Usher_syndrome,type_1D,601067/Deafness,autosomal_recessive_12,601386/Usher_syndrome,type_1D/F_digenic,601067/Pituitary_adenoma_5,multiple_types,617540]
chr10	73565915	73567173	3	14	2	   1.258	0.045	CDH23	0.00163				605516_[CDH23_Usher_syndrome,type_1D,601067/Deafness,autosomal_recessive_12,601386/Usher_syndrome,type_1D/F_digenic,601067/Pituitary_adenoma_5,multiple_types,617540]
chr10	73571062	73571357	1	4	2	   0.295	0.223	CDH23	0.10096				605516_[CDH23_Usher_syndrome,type_1D,601067/Deafness,autosomal_recessive_12,601386/Usher_syndrome,type_1D/F_digenic,601067/Pituitary_adenoma_5,multiple_types,617540]
chr10	89623185	89624315	3	6	1	   1.130	0.153	KLLN,PTEN	0.01891			PTEN	612105_[KLLN_Cowden_syndrome_4,615107],601728_[PTEN_Cowden_syndrome_1,158350/Lhermitte-Duclos_syndrome,158350/Meningioma,607174/Glioma_susceptibility_2,613028/Macrocephaly/autism_syndrome,605309/VATER_association_with_macrocephaly_and_ventriculomegaly,276950/Prostate_cancer,somatic,176807]
chr10	96058126	96058436	3	5	1	   0.310	0.115	PLCE1	0.01846				608414_[PLCE1_Nephrotic_syndrome,type_3,610725]
chr10	97373713	97373928	3	5	1	   0.215	0.051	ALDH18A1	0.03058				138250_[ALDH18A1_Cutis_laxa,autosomal_recessive,type_IIIA,219150/Spastic_paraplegia_9A,autosomal_dominant,601162/Spastic_paraplegia_9B,autosomal_recessive,616586/Cutis_laxa,autosomal_dominant_3,616603]
chr10	97515399	97515533	3	3	1	   0.134	0.185	ENTPD1,ENTPD1-AS1	0.08439				601752_[ENTPD1_Spastic_paraplegia_64,autosomal_recessive,615683]
chr10	101491707	101492433	3	6	1	   0.726	0.159	COX15,CUTC	0.01571				603646_[COX15_Leigh_syndrome_due_to_cytochrome_c_oxidase_deficiency,256000/Cardioencephalomyopathy,fatal_infantile,due_to_cytochrome_c_oxidase_deficiency_2,615119]
chr10	105792422	105792736	3	4	2	   0.314	0.057	COL17A1	0.01973				113811_[COL17A1_Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Epidermolysis_bullosa,junctional,localisata_variant,226650/Epithelial_recurrent_erosion_dystrophy,122400]
chr10	105803249	105803349	3	6	1	   0.100	0.134	COL17A1	0.01707				113811_[COL17A1_Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Epidermolysis_bullosa,junctional,localisata_variant,226650/Epithelial_recurrent_erosion_dystrophy,122400]
chr10	105809157	105809239	3	6	1	   0.082	0.045	COL17A1	0.00910				113811_[COL17A1_Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Epidermolysis_bullosa,junctional,localisata_variant,226650/Epithelial_recurrent_erosion_dystrophy,122400]
chr10	105823495	105836197	3	3	3	  12.702	0.076	COL17A1	0.03976				113811_[COL17A1_Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Epidermolysis_bullosa,junctional,localisata_variant,226650/Epithelial_recurrent_erosion_dystrophy,122400]
chr11	792860	792998	1	4	1	   0.138	0.057	SLC25A22	0.04017			SLC25A22	609302_[SLC25A22_Epileptic_encephalopathy,early_infantile,3,609304]
chr11	796033	796273	4	10	1	   0.240	0.185	SLC25A22	0.00187			SLC25A22	609302_[SLC25A22_Epileptic_encephalopathy,early_infantile,3,609304]
chr11	1862039	1862447	1	2	2	   0.408	0.217	TNNI2	0.24614				191043_[TNNI2_Arthrogryposis_multiplex_congenita,distal,type_2B,601680],600692_[TNNI2_Arthrogryposis,distal,type_2B,601680]
chr11	2187853	2188272	1	3	2	   0.419	0.191	TH	0.04356			TH	191290_[TH_Segawa_syndrome,recessive,605407]
chr11	3876923	3877649	3	14	1	   0.726	0.108	MIR4687,STIM1	0.00164				605921_[STIM1_Immunodeficiency_10,612783/Myopathy,tubular_aggregate,1_160565/Stormorken_syndrome,185070]
chr11	6638847	6640156	3	5	2	   1.309	0.102	TPP1	0.08642				607998_[TPP1_Ceroid_lipofuscinosis,neuronal,2,204500/Spinocerebellar_ataxia,autosomal_recessive_7,609270]
chr11	17538938	17539031	3	5	1	   0.093	0.083	USH1C	0.03283			USH1C	605242_[USH1C_Usher_syndrome,type_1C,276904/Deafness,autosomal_recessive_18A,602092]
chr11	17548760	17548888	1	3	1	   0.128	0.121	USH1C	0.07668			USH1C	605242_[USH1C_Usher_syndrome,type_1C,276904/Deafness,autosomal_recessive_18A,602092]
chr11	31832653	31832889	3	7	1	   0.236	0.121	PAX6	0.01571			PAX6	607108_[PAX6_Aniridia,106210/Cataract_with_late-onset_corneal_dystrophy,106210/Anterior_segment_dysgenesis_5,multiple_subtypes,604229/Foveal_hypoplasia_1,136520/Keratitis,148190/Optic_nerve_hypoplasia,165550/Morning_glory_disc_anomaly,120430/Coloboma_of_optic_nerve,120430/Coloboma,ocular,120200],606985_[PAX6_Aniridia_2,617141]
chr11	44331137	44331726	1	3	1	   0.589	0.166	ALX4	0.08439			ALX4	605420_[ALX4_Parietal_foramina_2,609597/Frontonasal_dysplasia_2,613451/Craniosynostosis_5,susceptibility_to,615529]
chr11	47236483	47238033	4	18	2	   1.550	0.172	DDB2	0.00323				600811_[DDB2_Xeroderma_pigmentosum,group_E,DDB-negative_subtype,278740]
chr11	47464198	47464376	3	5	1	   0.178	0.064	RAPSN	0.03196				601592_[RAPSN_Myasthenic_syndrome,congenital,11,associated_with_acetylcholine_receptor_deficiency,616326/Fetal_akinesia_deformation_sequence,208150]
chr11	62473665	62473797	4	6	1	   0.132	0.185	BSCL2,HNRNPUL2-BSCL2	0.01843				606158_[BSCL2_Lipodystrophy,congenital_generalized,type_2,269700/Silver_spastic_paraplegia_syndrome,270685/Neuropathy,distal_hereditary_motor,type_VA,600794/Encephalopathy,progressive,with_or_without_lipodystrophy,615924]
chr11	63978073	63978653	1	5	2	   0.580	0.076	FERMT3	0.01751				607901_[FERMT3_Leukocyte_adhesion_deficiency,type_III,612840]
chr11	65487506	65487645	4	17	1	   0.139	0.076	RNASEH2C	0.00016				610330_[RNASEH2C_Aicardi-Goutieres_syndrome_3,610329]
chr11	65635322	65635902	3	8	2	   0.580	0.038	EFEMP2	0.00022				604633_[EFEMP2_Cutis_laxa,autosomal_recessive,type_IB,614437]
chr11	66617398	66617597	3	5	1	   0.199	0.032	PC	0.02387				608786_[PC_Pyruvate_carboxylase_deficiency,266150]
chr11	67761137	67763365	1	6	2	   2.228	0.013	UNC93B1	0.01571				608204_[UNC93B1_Encephalopathy,acute,infection-induced_(herpes-specific),susceptibility_to,1,610551]
chr11	67764063	67764265	3	4	1	   0.202	0.127	UNC93B1	0.03898				608204_[UNC93B1_Encephalopathy,acute,infection-induced_(herpes-specific),susceptibility_to,1,610551]
chr11	67771117	67771278	1	4	1	   0.161	0.299	UNC93B1	0.10231				608204_[UNC93B1_Encephalopathy,acute,infection-induced_(herpes-specific),susceptibility_to,1,610551]
chr11	67811028	67811384	1	3	2	   0.356	0.070	TCIRG1	0.04322				604592_[TCIRG1_Osteopetrosis,autosomal_recessive_1,259700]
chr11	68216267	68216753	1	5	1	   0.486	0.172	LRP5	0.02613				603506_[LRP5_Osteoporosis-pseudoglioma_syndrome,259770/Bone_mineral_density_variability_1,601884/Hyperostosis,endosteal,144750/van_Buchem_disease,type_2,607636/Osteosclerosis,144750/Osteoporosis,166710/Exudative_vitreoretinopathy_4,601813/Osteopetrosis,autosomal_dominant_1,607634/Polycystic_liver_disease_4_with_or_without_kidney_cysts,617875]
chr11	68582792	68673716	3	4	2	  90.924	0.096	CPT1A,IGHMBP2	0.08142				600528_[CPT1A_CPT_deficiency,hepatic,type_IA,255120],600502_[IGHMBP2_Neuronopathy,distal_hereditary_motor,type_VI,604320/Charcot-Marie-Tooth_disease,axonal,type_2S,616155]
chr11	76894103	76894212	1	4	1	   0.109	0.025	MYO7A	0.02291				276903_[MYO7A_Usher_syndrome,type_1B,276900/Deafness,autosomal_recessive_2,600060/Deafness,autosomal_dominant_11,601317]
chr11	77850530	86749238	3	14	2	8898.708	0.185	ALG8,TMEM135	0.00480	yes	yes	FZD4	608103_[ALG8_Congenital_disorder_of_glycosylation,type_Ih,608104/Polycystic_liver_disease_3_with_or_without_kidney_cysts,617874],612803_[NARS2_Combined_oxidative_phosphorylation_deficiency_24,616239],610084_[TENM4_Essential_tremor,hereditary,5,616736],615533_[TMEM126B_Mitochondrial_complex_I_deficiency,nuclear_type_29,618250],612988_[TMEM126A_Optic_atrophy_7,612989],603025_[PICALM_Leukemia,acute_myeloid,somatic,601626],605984_[EED_Cohen-Gibson_syndrome,617561],614908_[HIKESHI_Leukodystrophy,hypomyelinating,13,616881],604579_[FZD4_Exudative_vitreoretinopathy_1,133780/Retinopathy_of_prematurity,133780]
chr11	88068095	88070951	3	7	2	   2.856	0.121	CTSC	0.00082				602365_[CTSC_Papillon-Lefevre_syndrome,245000/Haim-Munk_syndrome,245010/Periodontitis_1,juvenile,170650]
chr11	95657029	102980508	3	9	2	7323.479	0.102	MTMR2,DYNC2H1	0.00856	yes	yes	CNTN5	603557_[MTMR2_Charcot-Marie-Tooth_disease,type_4B1,601382],607537_[MAML2_Mucoepidermoid_salivary_gland_carcinoma],607311_[PGR_Progesterone_resistance,264080],603652_[TRPC6_Glomerulosclerosis,focal_segmental,2,603965],618058_[CFAP300_Ciliary_dyskinesia,primary,38,618063],606608_[YAP1_Coloboma,ocular,with_or_without_hearing_impairment,cleft_lip/palate,and/or_mental_retardation,120433],604629_[MMP20_Amelogenesis_imperfecta,type_IIA2,612529],120353_[MMP1_COPD,rate_of_decline_of_lung_function_in,606963/Epidermolysis_bullosa_dystrophica,autosomal_recessive,modifier_of,226600],185250_[MMP3_Coronary_heart_disease,susceptibility_to,6,614466],600108_[MMP13_Spondyloepimetaphyseal_dysplasia,Missouri_type,602111/Metaphyseal_anadysplasia_1,602111/Metaphyseal_dysplasia,Spahr_type,250400],603297_[DYNC2H1_Short-rib_thoracic_dysplasia_3_with_or_without_polydactyly,613091]
chr11	108005859	108005979	3	7	1	   0.120	0.045	ACAT1	0.00988				607809_[ACAT1_Alpha-methylacetoacetic_aciduria,203750]
chr11	108141781	108142143	3	4	2	   0.362	0.057	ATM	0.03360				607585_[ATM_Ataxia-telangiectasia,208900/Lymphoma,B-cell_non-Hodgkin,somatic/Breast_cancer,susceptibility_to,114480/Lymphoma,mantle_cell,somatic/T-cell_prolymphocytic_leukemia,somatic]
chr11	111741488	111742014	3	11	1	   0.526	0.134	ALG9	0.00123				606941_[ALG9_Congenital_disorder_of_glycosylation,type_Il,608776/Gillessen-Kaesbach-Nishimura_syndrome,263210]
chr11	118215049	118215203	3	7	1	   0.154	0.057	CD3G	0.00856				186740_[CD3G_Immunodeficiency_17,CD3_gamma_deficient,615607]
chr11	119215015	119215111	3	5	1	   0.096	0.178	C1QTNF5,MFRP	0.02479				606227_[MFRP_Microphthalmia,isolated_5,611040/Nanophthalmos_2,609549],608752_[C1QTNF5_Retinal_degeneration,late-onset,autosomal_dominant,605670]
chr12	464314	464425	3	4	1	   0.111	0.032	KDM5A	0.01144				
chr12	6439754	6439887	1	5	1	   0.133	0.051	TNFRSF1A	0.03097				191190_[TNFRSF1A_Periodic_fever,familial,142680/Multiple_sclerosis,susceptibility_to,5,614810]
chr12	6442893	6451293	3	14	3	   8.400	0.038	TNFRSF1A	0.00648				191190_[TNFRSF1A_Periodic_fever,familial,142680/Multiple_sclerosis,susceptibility_to,5,614810]
chr12	7341749	7343175	3	10	2	   1.426	0.115	PEX5	0.01854				600414_[PEX5_Peroxisome_biogenesis_disorder_2A_(Zellweger),214110/Peroxisome_biogenesis_disorder_2B,202370/Rhizomelic_chondrodysplasia_punctata,type_5,616716]
chr12	7356018	7360408	3	4	2	   4.390	0.127	PEX5	0.03047				600414_[PEX5_Peroxisome_biogenesis_disorder_2A_(Zellweger),214110/Peroxisome_biogenesis_disorder_2B,202370/Rhizomelic_chondrodysplasia_punctata,type_5,616716]
chr12	8757801	8758091	3	3	1	   0.290	0.236	AICDA	0.07715				605257_[AICDA_Immunodeficiency_with_hyper-IgM,type_2,605258]
chr12	31226769	31227035	3	6	1	   0.266	0.159	DDX11,DDX11-AS1	0.01612	yes			601150_[DDX11_Warsaw_breakage_syndrome,613398]
chr12	31255167	31255255	1	5	1	   0.088	0.178	DDX11	0.04132	yes			601150_[DDX11_Warsaw_breakage_syndrome,613398]
chr12	32906842	32908897	3	11	2	   2.055	0.083	YARS2	0.00000				610957_[YARS2_Myopathy,lactic_acidosis,and_sideroblastic_anemia_2,613561]
chr12	48298337	48298824	3	8	1	   0.487	0.146	VDR	0.01414				601769_[VDR_Rickets,vitamin_D-resistant,type_IIA,277440/Osteoporosis,involutional,166710]
chr12	48367862	48368655	1	3	2	   0.793	0.197	COL2A1	0.02753			COL2A1	120140_[COL2A1_Stickler_syndrome,type_I,108300/Kniest_dysplasia,156550/Achondrogenesis,type_II_or_hypochondrogenesis,200610/SED_congenita,183900/SMED_Strudwick_type,184250/Epiphyseal_dysplasia,multiple,with_myopia_and_deafness,132450/Spondyloperipheral_dysplasia,271700/Osteoarthritis_with_mild_chondrodysplasia,604864/Vitreoretinopathy_with_phalangeal_epiphyseal_dysplasia/Platyspondylic_skeletal_dysplasia,Torrance_type,151210/Avascular_necrosis_of_the_femoral_head,608805/Legg-Calve-Perthes_disease,150600/Stickler_sydrome,type_I,nonsyndromic_ocular,609508/Czech_dysplasia,609162/Spondyloepiphyseal_dysplasia,Stanescu_type,616583]
chr12	48380109	48381502	3	5	3	   1.393	0.159	COL2A1	0.13147			COL2A1	120140_[COL2A1_Stickler_syndrome,type_I,108300/Kniest_dysplasia,156550/Achondrogenesis,type_II_or_hypochondrogenesis,200610/SED_congenita,183900/SMED_Strudwick_type,184250/Epiphyseal_dysplasia,multiple,with_myopia_and_deafness,132450/Spondyloperipheral_dysplasia,271700/Osteoarthritis_with_mild_chondrodysplasia,604864/Vitreoretinopathy_with_phalangeal_epiphyseal_dysplasia/Platyspondylic_skeletal_dysplasia,Torrance_type,151210/Avascular_necrosis_of_the_femoral_head,608805/Legg-Calve-Perthes_disease,150600/Stickler_sydrome,type_I,nonsyndromic_ocular,609508/Czech_dysplasia,609162/Spondyloepiphyseal_dysplasia,Stanescu_type,616583]
chr12	49423174	49424561	3	4	2	   1.387	0.121	KMT2D	0.09199			KMT2D	602113_[KMT2D_Kabuki_syndrome_1,147920]
chr12	49436849	49436979	3	5	1	   0.130	0.070	KMT2D	0.02626			KMT2D	602113_[KMT2D_Kabuki_syndrome_1,147920]
chr12	49437641	49437791	3	4	1	   0.150	0.013	KMT2D	0.02988			KMT2D	602113_[KMT2D_Kabuki_syndrome_1,147920]
chr12	49440382	49440583	3	5	1	   0.201	0.025	KMT2D	0.01006			KMT2D	602113_[KMT2D_Kabuki_syndrome_1,147920]
chr12	51019749	51019840	3	6	1	   0.091	0.166	DIP2B	0.01579				611379_[DIP2B_Mental_retardation,FRA12A_type,136630]
chr12	51072452	51072669	3	3	1	   0.217	0.146	DIP2B	0.07493				611379_[DIP2B_Mental_retardation,FRA12A_type,136630]
chr12	51090834	51090968	3	11	1	   0.134	0.057	DIP2B	0.00244				611379_[DIP2B_Mental_retardation,FRA12A_type,136630]
chr12	53702734	53708235	3	5	4	   5.501	0.051	AAAS	0.06566				605378_[AAAS_Achalasia-addisonianism-alacrimia_syndrome,231550]
chr12	53714339	53715422	3	5	2	   1.083	0.268	AAAS	0.13845				605378_[AAAS_Achalasia-addisonianism-alacrimia_syndrome,231550]
chr12	56391033	56391133	3	7	1	   0.100	0.096	SUOX	0.01144				606887_[SUOX_Sulfite_oxidase_deficiency,272300]
chr12	56486521	56486614	3	4	1	   0.093	0.051	ERBB3	0.02613				190151_[ERBB3_Lethal_congenital_contractural_syndrome_2,607598/Erythroleukemia,familial,susceptibility_to,133180]
chr12	57976874	57977008	3	10	1	   0.134	0.083	KIF5A	0.00763				602821_[KIF5A_Spastic_paraplegia_10,autosomal_dominant,604187/Myoclonus,intractable,neonatal,617235/Amyotrophic_lateral_sclerosis,susceptibility_to,25,617921]
chr12	58158151	58158343	3	6	1	   0.192	0.057	CYP27B1	0.01707				609506_[CYP27B1_Vitamin_D-dependent_rickets,type_I,264700]
chr12	58176518	58176651	5	9	1	   0.133	0.242	TSFM	0.01463				604723_[TSFM_Combined_oxidative_phosphorylation_deficiency_3,610505]
chr12	65138579	65138697	3	7	1	   0.118	0.045	GNS	0.00970				607664_[GNS_Mucopolysaccharidosis_type_IIID,252940]
chr12	65152855	65153236	3	3	1	   0.381	0.248	GNS	0.05259				607664_[GNS_Mucopolysaccharidosis_type_IIID,252940]
chr12	66786078	66786292	3	3	1	   0.214	0.236	GRIP1	0.06762			GRIP1	604597_[GRIP1_Fraser_syndrome_3,617667]
chr12	81102293	81102403	1	4	1	   0.110	0.076	MYF6	0.03348				159991_[MYF6_Centronuclear_myopathy_3,614408]
chr12	102869411	102869587	3	3	1	   0.176	0.255	IGF1	0.05437				147440_[IGF1_Growth_retardation_with_deafness_and_mental_retardation_due_to_IGF1_deficiency,608747]
chr12	106773799	106773927	1	3	1	   0.128	0.229	POLR3B	0.05999				614366_[POLR3B_Leukodystrophy,hypomyelinating,8,with_or_without_oligodontia_and/or_hypogonadotropic_hypogonadism,614381]
chr12	109535913	109536453	3	4	1	   0.540	0.159	UNG	0.03761				191525_[UNG_Immunodeficiency_with_hyper_IgM,type_5,608106]
chr12	110011490	110011688	3	4	1	   0.198	0.153	MMAB,MVK	0.04239				607568_[MMAB_Methylmalonic_aciduria,vitamin_B12-responsive,due_to_defect_in_synthesis_of_adenosylcobalamin,cblB_complementation_type,251110],251170_[MVK_Mevalonic_aciduria,610377/Hyper-IgD_syndrome,260920/Porokeratosis_3,multiple_types,175900]
chr12	111953948	111954177	4	4	1	   0.229	0.357	ATXN2	0.07948				601517_[ATXN2_Spinocerebellar_ataxia_2,183090/Amyotrophic_lateral_sclerosis,susceptibility_to,13,183090/Parkinson_disease,late-onset,susceptibility_to,168600]
chr12	119624820	119624903	1	4	1	   0.083	0.064	HSPB8	0.04041				608014_[HSPB8_Neuropathy,distal_hereditary_motor,type_IIA,158590/Charcot-Marie-Tooth_disease,axonal,type_2L,608673]
chr12	120966733	120966974	4	10	1	   0.241	0.242	COQ5	0.00763				
chr12	122277423	122277964	3	7	2	   0.541	0.140	HPD	0.00026				609695_[HPD_Tyrosinemia,type_III,276710/Hawkinsinuria,140350]
chr12	122985177	123718481	3	7	2	 733.304	0.127	ZCCHC8,C12ORF65	0.00970	yes	yes		613541_[C12ORF65_Combined_oxidative_phosphorylation_deficiency_7,613559/Spastic_paraplegia_55,autosomal_recessive,615035]
chr13	32798362	32798532	3	3	1	   0.170	0.242	FRY	0.09674				
chr13	32852592	32868717	3	6	3	  16.125	0.146	FRY	0.01707				
chr13	52513177	52516700	3	7	3	   3.523	0.178	ATP7B	0.10452				606882_[ATP7B_Wilson_disease,277900]
chr13	108866876	108870726	3	3	2	   3.850	0.255	LIG4	0.03301				601837_[LIG4_LIG4_syndrome,606593/Multiple_myeloma,resistance_to,254500]
chr13	110831260	110831778	3	4	2	   0.518	0.229	COL4A1	0.10488				120130_[COL4A1_Porencephaly_1,175780/Brain_small_vessel_disease_with_or_without_ocular_anomalies,607595/Angiopathy,hereditary,with_nephropathy,aneurysms,and_muscle_cramps,611773/Hemorrhage,intracerebral,susceptibility_to,614519/Retinal_arteries,tortuosity_of,180000/Schizencephaly,269160]
chr13	111077071	111080940	3	4	2	   3.869	0.134	COL4A2	0.08600				120090_[COL4A2_Porencephaly_2,614483/Hemorrhage,intracerebral,susceptibility_to,614519]
chr13	111111108	111111291	3	3	1	   0.183	0.076	COL4A2,COL4A2-AS2	0.04497				120090_[COL4A2_Porencephaly_2,614483/Hemorrhage,intracerebral,susceptibility_to,614519]
chr13	111114615	111132747	3	9	5	  18.132	0.217	COL4A2,COL4A2-AS2	0.12688				120090_[COL4A2_Porencephaly_2,614483/Hemorrhage,intracerebral,susceptibility_to,614519]
chr13	111137992	111141865	3	5	2	   3.873	0.185	COL4A2	0.02112				120090_[COL4A2_Porencephaly_2,614483/Hemorrhage,intracerebral,susceptibility_to,614519]
chr14	20774036	20937704	3	4	2	 163.668	0.140	TTC5,PNP	0.02602				610107_[OSGEP_Galloway-Mowat_syndrome_3,617729],164050_[PNP_Immunodeficiency_due_to_purine_nucleoside_phosphorylase_deficiency,613179]
chr14	23895976	23896083	1	7	1	   0.107	0.389	MYH7	0.02582				160760_[MYH7_Cardiomyopathy,hypertrophic,1,192600/Cardiomyopathy,dilated,1S,613426/Myopathy,myosin_storage,autosomal_dominant,608358/Laing_distal_myopathy,160500/Scapuloperoneal_syndrome,myopathic_type,181430/Left_ventricular_noncompaction_5,613426/Myopathy,myosin_storage,autosomal_recessive,255160]
chr14	24723348	24723504	1	6	1	   0.156	0.032	TGM1	0.01865				190195_[TGM1_Ichthyosis,congenital,autosomal_recessive_1,242300]
chr14	24728900	24729274	1	5	2	   0.374	0.070	TGM1	0.01232				190195_[TGM1_Ichthyosis,congenital,autosomal_recessive_1,242300]
chr14	32030581	32030763	4	6	1	   0.182	0.248	NUBPL	0.06543				613621_[NUBPL_Mitochondrial_complex_I_deficiency,nuclear_type_21,618242]
chr14	35182870	35183033	3	10	1	   0.163	0.051	CFL2	0.00424				601443_[CFL2_Nemaline_myopathy_7,autosomal_recessive,610687]
chr14	45605126	45605752	3	8	1	   0.626	0.070	FANCM	0.01026				609644_[FANCM_Spermatogenic_failure_28,618086/Premature_ovarian_failure_15,618096]
chr14	50778719	50778957	3	4	1	   0.238	0.191	L2HGDH	0.04639				609584_[L2HGDH_L-2-hydroxyglutaric_aciduria,236792]
chr14	51026733	51027027	3	4	1	   0.294	0.172	ATL1	0.03348				606439_[ATL1_Spastic_paraplegia_3A,autosomal_dominant,182600/Neuropathy,hereditary_sensory,type_ID,613708]
chr14	55312476	55312580	3	10	1	   0.104	0.172	GCH1	0.00445				600225_[GCH1_Dystonia,DOPA-responsive,with_or_without_hyperphenylalaninemia,128230/Hyperphenylalaninemia,BH4-deficient,B,233910]
chr14	75469602	75470108	3	17	2	   0.506	0.070	EIF2B2	0.00119				606454_[EIF2B2_Leukoencephalopathy_with_vanishing_white_matter,603896/Ovarioleukodystrophy,603896]
chr14	77745062	77745222	1	5	1	   0.160	0.051	POMT2	0.02613				607439_[POMT2_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,2,613150/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,2,613156/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,2,613158]
chr14	77915626	77915710	3	5	1	   0.084	0.191	VIPAS39	0.04153				613401_[VIPAS39_Arthrogryposis,renal_dysfunction,and_cholestasis_2,613404]
chr14	77923428	77923993	3	9	1	   0.565	0.070	VIPAS39	0.01006				613401_[VIPAS39_Arthrogryposis,renal_dysfunction,and_cholestasis_2,613404]
chr15	23060805	23060915	3	4	1	   0.110	0.204	NIPA1	0.05315	yes		NIPA1	608145_[NIPA1_Spastic_paraplegia_6,autosomal_dominant,600363]
chr15	25200125	25200219	3	8	1	   0.094	0.134	SNRPN,SNURF	0.01087			SNRPN,SNURF	182279_[SNRPN_Prader-Willi_syndrome,176270]
chr15	25222014	25223475	3	5	3	   1.461	0.229	SNRPN,SNURF	0.13239			SNRPN,SNURF	182279_[SNRPN_Prader-Willi_syndrome,176270]
chr15	25599665	25601213	3	3	2	   1.548	0.006	SNHG14,UBE3A	0.02459			UBE3A	601623_[UBE3A_Angelman_syndrome,105830]
chr15	25653757	25654364	3	4	2	   0.607	0.210	SNHG14,UBE3A	0.10582			UBE3A	601623_[UBE3A_Angelman_syndrome,105830]
chr15	34610752	40698182	3	13	4	6087.430	0.064	SLC12A6,IVD	0.00988	yes	yes	GJD2,MEIS2,SPRED1	604878_[SLC12A6_Agenesis_of_the_corpus_callosum_with_peripheral_neuropathy,218000],606471_[NOP10_Dyskeratosis_congenita,autosomal_recessive_1,224230],102540_[ACTC1_Cardiomyopathy,dilated,1R,613424/Cardiomyopathy,hypertrophic,11,612098/Atrial_septal_defect_5,612794/Left_ventricular_noncompaction_4,613424],615626_[C15ORF41_Dyserythropoietic_anemia,congenital,type_Ib,615631],601740_[MEIS2_Cleft_palate,cardiac_defects,and_mental_retardation,600987],609291_[SPRED1_Legius_syndrome,611431],609280_[EIF2AK4_Pulmonary_venoocclusive_disease_2,234810],602860_[BUB1B_Colorectal_cancer,somatic,114500/Mosaic_variegated_aneuploidy_syndrome_1,257300/Premature_chromatid_separation_trait,176430],604114_[PLCB2_Platelet_PLC_beta-2_deficiency],607036_[IVD_Isovaleric_acidemia,243500]
chr15	40703449	40703562	3	3	1	   0.113	0.025	IVD	0.03405				607036_[IVD_Isovaleric_acidemia,243500]
chr15	45386751	45386899	3	6	1	   0.148	0.178	DUOX2	0.02479				606759_[DUOX2_Thyroid_dyshormonogenesis_6,607200]
chr15	45403299	45403485	1	8	1	   0.186	0.051	DUOX2	0.00964				606759_[DUOX2_Thyroid_dyshormonogenesis_6,607200]
chr15	48719754	48719980	1	3	1	   0.226	0.401	FBN1	0.36999			FBN1	134797_[FBN1_Marfan_syndrome,154700/Marfan_lipodystrophy_syndrome,616914/Ectopia_lentis,familial,129600/MASS_syndrome,604308/Weill-Marchesani_syndrome_2,dominant,608328/Stiff_skin_syndrome,184900/Acromicric_dysplasia,102370/Geleophysic_dysplasia_2,614185]
chr15	48784648	48787795	3	5	3	   3.147	0.236	FBN1	0.18267			FBN1	134797_[FBN1_Marfan_syndrome,154700/Marfan_lipodystrophy_syndrome,616914/Ectopia_lentis,familial,129600/MASS_syndrome,604308/Weill-Marchesani_syndrome_2,dominant,608328/Stiff_skin_syndrome,184900/Acromicric_dysplasia,102370/Geleophysic_dysplasia_2,614185]
chr15	49089848	49089937	3	6	1	   0.089	0.038	CEP152	0.01463				613529_[CEP152_Microcephaly_9,primary,autosomal_recessive,614852/Seckel_syndrome_5,613823]
chr15	51233853	51240366	3	4	2	   6.513	0.217	AP4E1	0.14931				607244_[AP4E1_Spastic_paraplegia_51,autosomal_recessive,613744/Stuttering,familial_persistent,1,184450]
chr15	52672009	52675395	3	8	2	   3.386	0.140	MYO5A	0.02334				160777_[MYO5A_Griscelli_syndrome,type_1,214450]
chr15	55522589	55522694	3	6	1	   0.105	0.185	RAB27A	0.02442				603868_[RAB27A_Griscelli_syndrome,type_2,607624]
chr15	72978510	72978602	4	5	1	   0.092	0.217	BBS4	0.02682			BBS4	600374_[BBS4_Bardet-Biedl_syndrome_4,615982]
chr15	74490083	74494633	3	3	2	   4.550	0.268	STRA6	0.22798				610745_[STRA6_Microphthalmia,syndromic_9,601186/Microphthalmia,isolated,with_coloboma_8,601186]
chr15	76668493	76668662	3	3	1	   0.169	0.178	SCAPER	0.05619				611611_[SCAPER_Intellectual_developmental_disorder_and_retinitis_pigmentosa,618195]
chr15	80445223	80445487	4	4	1	   0.264	0.236	FAH	0.04234				613871_[FAH_Tyrosinemia,type_I,276700]
chr15	91260569	91260681	3	11	1	   0.112	0.127	BLM	0.00083				604610_[BLM_Bloom_syndrome,210900]
chr15	91565374	91565843	4	27	1	   0.469	0.217	VPS33B	0.00000				608552_[VPS33B_Arthrogryposis,renal_dysfunction,and_cholestasis_1,208085]
chr16	1244962	1245575	1	5	2	   0.613	0.127	CACNA1H	0.07336			CACNA1H	607904_[CACNA1H_Epilepsy,idiopathic_generalized,susceptibility_to,6,611942/Epilepsy,childhood_absence,susceptibility_to,6,611942/Hyperaldosteronism,familial,type_IV,617027]
chr16	1260025	1260661	1	2	3	   0.636	0.108	CACNA1H	0.15015			CACNA1H	607904_[CACNA1H_Epilepsy,idiopathic_generalized,susceptibility_to,6,611942/Epilepsy,childhood_absence,susceptibility_to,6,611942/Hyperaldosteronism,familial,type_IV,617027]
chr16	1261158	1261616	1	3	2	   0.458	0.064	CACNA1H	0.05061			CACNA1H	607904_[CACNA1H_Epilepsy,idiopathic_generalized,susceptibility_to,6,611942/Epilepsy,childhood_absence,susceptibility_to,6,611942/Hyperaldosteronism,familial,type_IV,617027]
chr16	1505125	1505806	1	5	2	   0.681	0.102	CLCN7	0.08465				602727_[CLCN7_Osteopetrosis,autosomal_recessive_4,611490/Osteopetrosis,autosomal_dominant_2,166600]
chr16	1507685	1510959	1	8	3	   3.274	0.038	CLCN7	0.03623	yes			602727_[CLCN7_Osteopetrosis,autosomal_recessive_4,611490/Osteopetrosis,autosomal_dominant_2,166600]
chr16	2134942	2135333	1	3	2	   0.391	0.178	TSC2	0.14448			TSC2	191092_[TSC2_Tuberous_sclerosis-2,613254/Lymphangioleiomyomatosis,somatic,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr16	2152372	2152644	3	4	1	   0.272	0.038	PKD1	0.03902	yes		PKD1	601313_[PKD1_Polycystic_kidney_disease_1,173900]
chr16	2334270	2335009	1	4	2	   0.739	0.019	ABCA3	0.03545				601615_[ABCA3_Surfactant_metabolism_dysfunction,pulmonary,3,610921]
chr16	2549348	2549941	1	4	2	   0.593	0.140	TBC1D24	0.12455				613577_[TBC1D24_Myoclonic_epilepsy,infantile,familial,605021/Epileptic_encephalopathy,early_infantile,16,615338/DOORS_syndrome,220500/Deafness,autosomal_recessive_86,614617/Deafness,autosomal_dominant_65,616044]
chr16	5130937	5131067	1	4	1	   0.130	0.057	ALG1	0.03272				605907_[ALG1_Congenital_disorder_of_glycosylation,type_Ik,608540]
chr16	9862698	9862956	1	3	1	   0.258	0.134	GRIN2A	0.03214			GRIN2A	138253_[GRIN2A_Epilepsy,focal,with_speech_disorder_and_with_or_without_mental_retardation,245570]
chr16	10275724	10276621	1	6	2	   0.897	0.057	GRIN2A	0.00163			GRIN2A	138253_[GRIN2A_Epilepsy,focal,with_speech_disorder_and_with_or_without_mental_retardation,245570]
chr16	10971045	10971249	4	6	1	   0.204	0.280	CIITA	0.03097				600005_[CIITA_Bare_lymphocyte_syndrome,type_II,complementation_group_A,209920/Rheumatoid_arthritis,susceptibility_to,180300]
chr16	11009417	11010326	3	8	2	   0.909	0.146	CIITA	0.01385				600005_[CIITA_Bare_lymphocyte_syndrome,type_II,complementation_group_A,209920/Rheumatoid_arthritis,susceptibility_to,180300]
chr16	11645553	11645670	4	4	1	   0.117	0.280	LITAF	0.12701				603795_[LITAF_Charcot-Marie-Tooth_disease,type_1C,601098]
chr16	23464137	23464522	3	9	1	   0.385	0.115	COG7	0.01105				606978_[COG7_Congenital_disorder_of_glycosylation,type_IIe,608779]
chr16	28502793	28503633	3	11	2	   0.840	0.140	CLN3	0.01277				607042_[CLN3_Ceroid_lipofuscinosis,neuronal,3,204200]
chr16	28857529	28857739	4	9	1	   0.210	0.197	TUFM	0.00964				602389_[TUFM_Combined_oxidative_phosphorylation_deficiency_4,610678]
chr16	28947823	28947931	4	8	1	   0.108	0.268	CD19	0.00884				107265_[CD19_Immunodeficiency,common_variable,3,613493]
chr16	30064401	30064548	5	15	1	   0.147	0.242	ALDOA	0.00082			ALDOA	103850_[ALDOA_Glycogen_storage_disease_XII,611881]
chr16	30066483	30066658	3	8	1	   0.175	0.089	ALDOA	0.01058			ALDOA	103850_[ALDOA_Glycogen_storage_disease_XII,611881]
chr16	30078761	30080309	3	9	2	   1.548	0.019	ALDOA	0.01288			ALDOA	103850_[ALDOA_Glycogen_storage_disease_XII,611881]
chr16	30198693	30198832	6	25	1	   0.139	0.166	CORO1A	0.00000	yes	yes		605000_[CORO1A_Immunodeficiency_8,615401]
chr16	31202274	31202441	3	4	1	   0.167	0.217	FUS	0.04681				137070_[FUS_Amyotrophic_lateral_sclerosis_6,with_or_without_frontotemporal_dementia,608030/Essential_tremor,hereditary,4,614782]
chr16	53674935	53675038	3	3	1	   0.103	0.127	RPGRIP1L	0.09294				610937_[RPGRIP1L_Joubert_syndrome_7,611560/Meckel_syndrome_5,611561/COACH_syndrome,216360]
chr16	66503495	66503778	1	4	1	   0.283	0.032	BEAN1	0.03272				612051_[BEAN1_Spinocerebellar_ataxia_31,117210]
chr16	66551029	66551128	4	12	1	   0.099	0.191	TK2	0.00182				188250_[TK2_Mitochondrial_DNA_depletion_syndrome_2_(myopathic_type),609560/Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions,autosomal_recessive_3,617069]
chr16	66583831	66584325	3	7	1	   0.494	0.096	TK2	0.01571				188250_[TK2_Mitochondrial_DNA_depletion_syndrome_2_(myopathic_type),609560/Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions,autosomal_recessive_3,617069]
chr16	70288514	70288647	1	6	1	   0.133	0.083	AARS	0.01571				601065_[AARS_Charcot-Marie-Tooth_disease,axonal,type_2N,613287/Epileptic_encephalopathy,early_infantile,29,616339]
chr16	70323314	70323422	3	3	1	   0.108	0.178	AARS	0.06894				601065_[AARS_Charcot-Marie-Tooth_disease,axonal,type_2N,613287/Epileptic_encephalopathy,early_infantile,29,616339]
chr16	89251571	89254703	3	7	3	   3.132	0.089	CDH15	0.03700				114019_[CDH15_Mental_retardation,autosomal_dominant_3,612580]
chr17	3539752	3540135	3	9	1	   0.383	0.115	CTNS	0.00856			CTNS	606272_[CTNS_Cystinosis,nephropathic,219800/Cystinosis,ocular_nonnephropathic,219750/Cystinosis,late-onset_juvenile_or_adolescent_nephropathic,219900/Cystinosis,atypical_nephropathic,219800]
chr17	7124233	7124387	3	7	1	   0.154	0.102	ACADVL	0.01192				609575_[ACADVL_VLCAD_deficiency,201475]
chr17	7348396	7348514	4	7	1	   0.118	0.166	CHRNB1	0.01118				100710_[CHRNB1_Myasthenic_syndrome,congenital,2A,slow-channel,616313/Myasthenic_syndrome,congenital,2C,associated_with_acetylcholine_receptor_deficiency,616314]
chr17	7359103	7359270	3	6	1	   0.167	0.134	CHRNB1	0.01378				100710_[CHRNB1_Myasthenic_syndrome,congenital,2A,slow-channel,616313/Myasthenic_syndrome,congenital,2C,associated_with_acetylcholine_receptor_deficiency,616314]
chr17	10297556	10297779	3	3	1	   0.223	0.096	MYH8	0.02682				160741_[MYH8_Carney_complex_variant,608837/Trismus-pseudocamptodactyly_syndrome,158300]
chr17	10600542	10600895	3	6	1	   0.353	0.159	SCO1	0.01854				603644_[SCO1_Mitochondrial_complex_IV_deficiency,220110]
chr17	19552054	19552447	3	10	1	   0.393	0.127	ALDH3A2	0.00331				609523_[ALDH3A2_Sjogren-Larsson_syndrome,270200]
chr17	33904905	33905666	3	4	1	   0.761	0.134	PEX12	0.01463				601758_[PEX12_Peroxisome_biogenesis_disorder_3A_(Zellweger),614859/Peroxisome_biogenesis_disorder_3B,266510]
chr17	38804015	38804113	5	8	1	   0.098	0.274	KRT222,SMARCE1	0.03019				603111_[SMARCE1_Meningioma,familial,susceptibility_to,607174/Coffin-Siris_syndrome_5,616938]
chr17	40474290	40474522	1	6	1	   0.232	0.083	STAT3	0.01240				102582_[STAT3_Hyper-IgE_recurrent_infection_syndrome,147060/Autoimmune_disease,multisystem,infantile-onset,1,615952]
chr17	40475012	40475171	3	8	1	   0.159	0.064	STAT3	0.00810				102582_[STAT3_Hyper-IgE_recurrent_infection_syndrome,147060/Autoimmune_disease,multisystem,infantile-onset,1,615952]
chr17	46023217	46023365	3	3	1	   0.148	0.102	PNPO	0.07435				603287_[PNPO_Pyridoxamine_5'-phosphate_oxidase_deficiency,610090]
chr17	48673913	48674017	1	3	1	   0.104	0.172	CACNA1G	0.10470				604065_[CACNA1G_Spinocerebellar_ataxia_42,616795/Spinocerebellar_ataxia_42,early-onset,severe,with_neurodevelopmental_deficits,618087]
chr17	48681506	48683394	1	7	2	   1.888	0.025	CACNA1G	0.05167				604065_[CACNA1G_Spinocerebellar_ataxia_42,616795/Spinocerebellar_ataxia_42,early-onset,severe,with_neurodevelopmental_deficits,618087]
chr17	56296502	56296976	3	10	2	   0.474	0.178	LPO,MKS1	0.00337				609883_[MKS1_Meckel_syndrome_1,249000/Bardet-Biedl_syndrome_13,615990/Joubert_syndrome_28,617121]
chr17	57078949	57079085	3	4	1	   0.136	0.223	TRIM37	0.05220				605073_[TRIM37_Mulibrey_nanism,253250]
chr17	62009545	62009714	4	15	1	   0.169	0.083	CD79B	0.00026				147245_[CD79B_Agammaglobulinemia_6,612692]
chr17	62488774	62493194	3	10	3	   4.420	0.102	POLG2	0.00700				604983_[POLG2_Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions,autosomal_dominant_4,610131]
chr17	75372155	75372490	3	5	1	   0.335	0.102	SEPT9	0.02667				604061_[SEPT9_Leukemia,acute_myeloid,therapy-related/Ovarian_carcinoma/Amyotrophy,hereditary_neuralgic,162100]
chr17	76115042	76115137	1	6	1	   0.095	0.076	TMC6	0.01843				605828_[TMC6_Epidermodysplasia_verruciformis,226400]
chr17	76129924	76130091	3	6	1	   0.167	0.057	TMC8	0.01920				605829_[TMC8_Epidermodysplasia_verruciformis_2,618231]
chr17	76130941	76131100	1	6	1	   0.159	0.057	TMC8	0.01920				605829_[TMC8_Epidermodysplasia_verruciformis_2,618231]
chr17	78082079	78082416	1	5	2	   0.337	0.083	GAA	0.01920				606800_[GAA_Glycogen_storage_disease_II,232300]
chr17	80038236	80038476	3	4	1	   0.240	0.115	FASN	0.03483				
chr17	80045820	80046762	1	7	4	   0.942	0.102	FASN	0.06827				
chr18	2931244	2931451	3	7	1	   0.207	0.057	LPIN2	0.02458				605519_[LPIN2_Majeed_syndrome,609628]
chr18	2960637	2960857	3	8	1	   0.220	0.115	LPIN2	0.00636				605519_[LPIN2_Majeed_syndrome,609628]
chr18	3447598	3453864	3	33	4	   6.266	0.121	TGIF1	0.00000			TGIF1	602630_[TGIF1_Holoprosencephaly_4,142946]
chr18	6999434	7002394	3	4	3	   2.960	0.121	LAMA1	0.05377				150320_[LAMA1_Poretti-Boltshauser_syndrome,615960]
chr18	9117826	9119598	3	5	3	   1.772	0.019	NDUFV2	0.02968				600532_[NDUFV2_Mitochondrial_complex_I_deficiency,nuclear_type_7,618229]
chr18	21119309	21119444	3	13	1	   0.135	0.057	NPC1	0.00156				607623_[NPC1_Niemann-Pick_disease,type_C1,257220/Niemann-Pick_disease,type_D,257220]
chr18	21120402	21121182	3	18	2	   0.780	0.076	NPC1	0.00004				607623_[NPC1_Niemann-Pick_disease,type_C1,257220/Niemann-Pick_disease,type_D,257220]
chr18	21363977	21364131	3	3	1	   0.154	0.306	LAMA3	0.05999				600805_[LAMA3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,generalized_atrophic_benign,226650/Laryngoonychocutaneous_syndrome,245660]
chr18	21396342	21396461	3	4	1	   0.119	0.236	LAMA3	0.05332				600805_[LAMA3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,generalized_atrophic_benign,226650/Laryngoonychocutaneous_syndrome,245660]
chr18	21416935	21417063	3	3	1	   0.128	0.064	LAMA3	0.03429				600805_[LAMA3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,generalized_atrophic_benign,226650/Laryngoonychocutaneous_syndrome,245660]
chr18	21422349	21422495	3	3	1	   0.146	0.025	LAMA3	0.02988				600805_[LAMA3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,generalized_atrophic_benign,226650/Laryngoonychocutaneous_syndrome,245660]
chr18	21479242	21481297	3	3	2	   2.055	0.255	LAMA3	0.23784				600805_[LAMA3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,generalized_atrophic_benign,226650/Laryngoonychocutaneous_syndrome,245660]
chr18	21526098	21529898	3	3	2	   3.800	0.172	LAMA3	0.08114				600805_[LAMA3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,generalized_atrophic_benign,226650/Laryngoonychocutaneous_syndrome,245660]
chr18	33709827	33710044	4	14	1	   0.217	0.204	ELP2	0.00044				616054_[ELP2_Mental_retardation,autosomal_recessive_58,617270]
chr18	33722234	33722320	3	4	1	   0.086	0.076	ELP2	0.01920				616054_[ELP2_Mental_retardation,autosomal_recessive_58,617270]
chr18	33747054	33747195	1	3	1	   0.141	0.032	ELP2	0.02682				616054_[ELP2_Mental_retardation,autosomal_recessive_58,617270]
chr18	53255259	53257055	3	6	2	   1.796	0.255	TCF4	0.04579			TCF4	602272_[TCF4_Pitt-Hopkins_syndrome,610954/Corneal_dystrophy,Fuchs_endothelial,3,613267]
chr19	853252	853413	1	4	1	   0.161	0.197	ELANE	0.05220				130130_[ELANE_Neutropenia,cyclic,162800/Neutropenia,severe_congenital_1,autosomal_dominant,202700]
chr19	4095376	4095457	1	5	1	   0.081	0.083	MAP2K2	0.02518			MAP2K2	601263_[MAP2K2_Cardiofaciocutaneous_syndrome_4,615280]
chr19	6693413	6693508	1	4	1	   0.095	0.013	C3	0.02518			C3	120700_[C3_C3_deficiency,613779/Hemolytic_uremic_syndrome,atypical,susceptibility_to,5,612925/Macular_degeneration,age-related,9,611378]
chr19	7598635	7598905	3	4	1	   0.270	0.217	MCOLN1,PNPLA6	0.02876				605248_[MCOLN1_Mucolipidosis_IV,252650],603197_[PNPLA6_Spastic_paraplegia_39,autosomal_recessive,612020/Boucher-Neuhauser_syndrome,215470/Laurence-Moon_syndrome,245800/Oliver-McFarlane_syndrome,275400]
chr19	7706581	7706749	4	7	1	   0.168	0.242	STXBP2	0.01780				601717_[STXBP2_Hemophagocytic_lymphohistiocytosis,familial,5,613101]
chr19	7707859	7708141	1	2	2	   0.282	0.172	STXBP2	0.15485				601717_[STXBP2_Hemophagocytic_lymphohistiocytosis,familial,5,613101]
chr19	7711125	7711240	1	4	1	   0.115	0.032	STXBP2	0.03000				601717_[STXBP2_Hemophagocytic_lymphohistiocytosis,familial,5,613101]
chr19	10252694	10252906	3	6	1	   0.212	0.038	DNMT1	0.01571				126375_[DNMT1_Neuropathy,hereditary_sensory,type_IE,614116/Cerebellar_ataxia,deafness,and_narcolepsy,autosomal_dominant,604121]
chr19	10260119	10260343	3	6	1	   0.224	0.076	DNMT1	0.01843				126375_[DNMT1_Neuropathy,hereditary_sensory,type_IE,614116/Cerebellar_ataxia,deafness,and_narcolepsy,autosomal_dominant,604121]
chr19	11151964	11152246	1	3	1	   0.282	0.032	SMARCA4	0.03195			SMARCA4	603254_[SMARCA4_Rhabdoid_tumor_predisposition_syndrome_2,613325/Coffin-Siris_syndrome_4,614609]
chr19	12758037	12758422	3	3	2	   0.385	0.025	MAN2B1	0.04069				609458_[MAN2B1_Mannosidosis,alpha-,types_I_and_II,248500]
chr19	12767375	12767880	3	9	2	   0.505	0.057	MAN2B1	0.00423				609458_[MAN2B1_Mannosidosis,alpha-,types_I_and_II,248500]
chr19	12776156	12917903	3	23	4	 141.747	0.025	MAN2B1,RNASEH2A	0.00198				609458_[MAN2B1_Mannosidosis,alpha-,types_I_and_II,248500],606034_[RNASEH2A_Aicardi-Goutieres_syndrome_4,610333]
chr19	13215704	13215905	3	9	1	   0.201	0.096	TRMT1	0.00794				
chr19	13616736	13617284	1	3	1	   0.548	0.229	CACNA1A	0.09919			CACNA1A	601011_[CACNA1A_Migraine,familial_hemiplegic,1,141500/Episodic_ataxia,type_2,108500/Spinocerebellar_ataxia_6,183086/Migraine,familial_hemiplegic,1,with_progressive_cerebellar_ataxia,141500/Epileptic_encephalopathy,early_infantile,42,617106]
chr19	14023971	14029017	3	6	3	   5.046	0.127	CC2D1A	0.02602				610055_[CC2D1A_Mental_retardation,autosomal_recessive_3,608443]
chr19	14037320	14037413	3	5	1	   0.093	0.051	CC2D1A	0.01940				610055_[CC2D1A_Mental_retardation,autosomal_recessive_3,608443]
chr19	15298682	15299169	3	6	2	   0.487	0.185	NOTCH3	0.04967			NOTCH3	600276_[NOTCH3_Cerebral_arteriopathy_with_subcortical_infarcts_and_leukoencephalopathy_1,125310/Myofibromatosis,infantile_2,615293/Lateral_meningocele_syndrome,130720]
chr19	17942473	17942617	3	5	1	   0.144	0.172	JAK3	0.03882				600173_[JAK3_SCID,autosomal_recessive,T-negative/B-positive_type,600802]
chr19	17954576	17955249	3	3	2	   0.673	0.166	JAK3	0.07702				600173_[JAK3_SCID,autosomal_recessive,T-negative/B-positive_type,600802]
chr19	18001685	18001820	3	5	1	   0.135	0.045	SLC5A5	0.02459				601843_[SLC5A5_Thyroid_dyshormonogenesis_1,274400]
chr19	19307762	19308070	3	6	2	   0.308	0.057	RFXANK	0.01768				603200_[RFXANK_MHC_class_II_deficiency,complementation_group_B,209920]
chr19	33991834	34002071	1	10	2	  10.237	0.032	PEPD	0.02334				613230_[PEPD_Prolidase_deficiency,170100]
chr19	34868398	34868501	3	5	1	   0.103	0.076	GPI	0.03898				172400_[GPI_Hemolytic_anemia,nonspherocytic,due_to_glucose_phosphate_isomerase_deficiency,613470]
chr19	36139115	36139315	1	4	1	   0.200	0.019	COX6B1	0.02459				124089_[COX6B1_Mitochondrial_complex_IV_deficiency,220110]
chr19	36339868	36340565	3	7	3	   0.697	0.070	NPHS1	0.02387				602716_[NPHS1_Nephrotic_syndrome,type_1,256300]
chr19	36486080	36487230	3	3	1	   1.150	0.185	SDHAF1	0.06827				612848_[SDHAF1_Mitochondrial_complex_II_deficiency,252011]
chr19	36592106	36592229	1	4	1	   0.123	0.076	WDR62	0.02551				613583_[WDR62_Microcephaly_2,primary,autosomal_recessive,with_or_without_cortical_malformations,604317]
chr19	38955269	38955372	1	4	1	   0.103	0.019	RYR1	0.02112				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	38965948	38966100	3	4	1	   0.152	0.089	RYR1	0.04132				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	38980706	38980926	3	7	1	   0.220	0.083	RYR1	0.03312				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	38984982	38985275	3	3	1	   0.293	0.210	RYR1	0.05775				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	39037075	39037176	1	3	1	   0.101	0.045	RYR1	0.01900				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	41903684	41903850	5	8	1	   0.166	0.274	BCKDHA	0.01429				608348_[BCKDHA_Maple_syrup_urine_disease,type_Ia,248600]
chr19	42383050	42383369	1	6	1	   0.319	0.083	CD79A	0.01843				112205_[CD79A_Agammaglobulinemia_3,613501]
chr19	44010861	44012222	1	13	2	   1.361	0.051	ETHE1	0.00016				608451_[ETHE1_Ethylmalonic_encephalopathy,602473]
chr19	44015579	44030821	4	20	3	  15.242	0.166	ETHE1,ZNF575	0.00500				608451_[ETHE1_Ethylmalonic_encephalopathy,602473]
chr19	45924426	45927187	4	6	3	   2.761	0.210	ERCC1	0.00491				126380_[ERCC1_Cerebrooculofacioskeletal_syndrome_4,610758]
chr19	45992096	45992821	3	10	2	   0.725	0.083	PPM1N,RTN2	0.00874				603183_[RTN2_Spastic_paraplegia_12,autosomal_dominant,604805]
chr19	47251274	47251984	3	3	2	   0.710	0.115	FKRP	0.04135				606596_[FKRP_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,5,613153/Muscular_dystrophy-dystroglycanopathy_(congenital_with_or_without_mental_retardation),type_B,5,606612/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,5,607155]
chr19	50365432	50365548	3	3	1	   0.116	0.096	PNKP	0.05144				605610_[PNKP_Microcephaly,seizures,and_developmental_delay,613402/Ataxia-oculomotor_apraxia_4,616267]
chr19	51869514	51869682	6	35	1	   0.168	0.172	ETFB	0.00000				130410_[ETFB_Glutaric_acidemia_IIB,231680]
chr19	54392882	54393281	3	6	2	   0.399	0.210	PRKCG	0.01378				176980_[PRKCG_Spinocerebellar_ataxia_14,605361]
chr20	3869476	3870589	4	7	2	   1.113	0.159	PANK2	0.00737				606157_[PANK2_Neurodegeneration_with_brain_iron_accumulation_1,234200/HARP_syndrome,607236]
chr20	13765662	13765946	4	3	1	   0.284	0.363	NDUFAF5	0.08602				612360_[NDUFAF5_Mitochondrial_complex_I_deficiency,nuclear_type_16,616238]
chr20	25287459	25288691	1	3	2	   1.232	0.045	ABHD12	0.02862				613599_[ABHD12_Polyneuropathy,hearing_loss,ataxia,retinitis_pigmentosa,and_cataract,612674]
chr20	33539517	33543611	3	3	2	   4.094	0.242	GSS	0.08631				601002_[GSS_Hemolytic_anemia_due_to_glutathione_synthetase_deficiency,231900/Glutathione_synthetase_deficiency,266130]
chr20	35555575	35559288	3	9	2	   3.713	0.070	SAMHD1	0.00557				606754_[SAMHD1_Aicardi-Goutieres_syndrome_5,612952/Chilblain_lupus_2,614415]
chr20	35569432	35580256	3	8	3	  10.824	0.076	SAMHD1	0.02602				606754_[SAMHD1_Aicardi-Goutieres_syndrome_5,612952/Chilblain_lupus_2,614415]
chr20	44520545	44520676	3	3	1	   0.131	0.197	CTSA	0.07702				613111_[CTSA_Galactosialidosis,256540]
chr20	57478717	57480545	3	12	2	   1.828	0.038	GNAS	0.00005			GNAS	139320_[GNAS_Pseudohypoparathyroidism_Ia,103580/McCune-Albright_syndrome,somatic,mosaic_174800/Pseudohypoparathyroidism_Ic,612462/Osseous_heteroplasia,progressive,166350/Pseudohypoparathyroidism_Ib,603233/Pituitary_adenoma_3,multiple_types,somatic,617686/Pseudopseudohypoparathyroidism,612463/ACTH-independent_macronodular_adrenal_hyperplasia,219080]
chr20	57485379	57485466	3	4	1	   0.087	0.076	GNAS	0.03967			GNAS	139320_[GNAS_Pseudohypoparathyroidism_Ia,103580/McCune-Albright_syndrome,somatic,mosaic_174800/Pseudohypoparathyroidism_Ic,612462/Osseous_heteroplasia,progressive,166350/Pseudohypoparathyroidism_Ib,603233/Pituitary_adenoma_3,multiple_types,somatic,617686/Pseudopseudohypoparathyroidism,612463/ACTH-independent_macronodular_adrenal_hyperplasia,219080]
chr20	61987299	61991061	1	4	2	   3.762	0.064	CHRNA4	0.07625	yes		CHRNA4	118504_[CHRNA4_Epilepsy,nocturnal_frontal_lobe,1,600513/Nicotine_addiction,susceptibility_to,188890]
chr20	62073749	62073894	1	4	1	   0.145	0.045	KCNQ2	0.03047			KCNQ2	602235_[KCNQ2_Seizures,benign_neonatal,1,121200/Myokymia,121200/Epileptic_encephalopathy,early_infantile,7,613720]
chr21	46915262	46915356	1	4	1	   0.094	0.025	COL18A1	0.02698				120328_[COL18A1_Knobloch_syndrome,type_1,267750]
chr21	46925742	46925890	3	3	1	   0.148	0.083	COL18A1,SLC19A1	0.04534				120328_[COL18A1_Knobloch_syndrome,type_1,267750]
chr21	47421157	47421310	1	5	1	   0.153	0.032	COL6A1	0.02602			COL6A1	120220_[COL6A1_Bethlem_myopathy_1,158810/Ullrich_congenital_muscular_dystrophy_1,254090]
chr21	47832741	47832916	1	4	1	   0.175	0.096	PCNT	0.04646				605925_[PCNT_Microcephalic_osteodysplastic_primordial_dwarfism,type_II,210720]
chr22	24916345	24919751	3	3	2	   3.406	0.051	UPB1	0.06827				606673_[UPB1_Beta-ureidopropionase_deficiency,613161]
chr22	37257020	37260181	3	3	2	   3.161	0.197	NCF4,NCF4-AS1	0.08142				601488_[NCF4_Granulomatous_disease,chronic,autosomal_recessive,cytochrome_b-positive,type_III,613960]
chr22	38577661	38577771	5	32	1	   0.110	0.146	PLA2G6	0.00000				603604_[PLA2G6_Infantile_neuroaxonal_dystrophy_1,256600/Neurodegeneration_with_brain_iron_accumulation_2B,610217/Parkinson_disease_14,autosomal_recessive,612953]
chr22	40754858	40755049	3	9	1	   0.191	0.025	ADSL	0.00331				608222_[ADSL_Adenylosuccinase_deficiency,103050]
chr22	41253075	41256807	3	12	2	   3.732	0.261	XPNPEP3,DNAJB7	0.01920				613553_[XPNPEP3_Nephronophthisis-like_nephropathy_1,613159]
chr22	42466276	42466856	3	6	1	   0.580	0.210	NAGA	0.01707				104170_[NAGA_Schindler_disease,type_I,609241/Kanzaki_disease,609242/Schindler_disease,type_III,609241]
chr22	42523439	42526893	1	26	6	   3.454	0.045	CYP2D6,NDUFA6-DT	0.00223	yes	yes	CYP2D6	124030_[CYP2D6_Debrisoquine_sensitivity,608902/Codeine_sensitivity,608902]
chr22	50965584	50967049	3	3	3	   1.465	0.076	TYMP	0.05999				131222_[TYMP_Mitochondrial_DNA_depletion_syndrome_1_(MNGIE_type),603041]
chrX	49086919	49087081	2	7	1	   0.162	0.006	CACNA1F	0.10226				300110_[CACNA1F_Night_blindness,congenital_stationary_(incomplete),2A,X-linked,300071/Cone-rod_dystrophy,X-linked,3,300476/Aland_Island_eye_disease,300600]
